
<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
      
      
        <link rel="canonical" href="http://spbm.ohio.gainwelltechnologies.com/UPDL%20and%20Supporting%20Documents/Supporting%20Documents/preferred_drug_list/">
      
      
        <link rel="prev" href="../payable_active_ingredients/">
      
      
        <link rel="next" href="../quantity/">
      
      
      <link rel="icon" href="../../../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.6.1, mkdocs-material-9.5.36">
    
    
      
        <title>Preferred Drug List - Ohio SPBM Demo</title>
      
    
    
      <link rel="stylesheet" href="../../../assets/stylesheets/main.06209087.min.css">
      
        
        <link rel="stylesheet" href="../../../assets/stylesheets/palette.06af60db.min.css">
      
      


    
    
      
    
    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
    <script>__md_scope=new URL("../../..",location),__md_hash=e=>[...e].reduce(((e,_)=>(e<<5)-e+_.charCodeAt(0)),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="gainwell" data-md-color-primary="indigo" data-md-color-accent="indigo">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
        
        <a href="#preferred_drug_list" class="md-skip">
          Skip to content
        </a>
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

<header class="md-header" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href="../../.." title="Ohio SPBM Demo" class="md-header__button md-logo" aria-label="Ohio SPBM Demo" data-md-component="logo">
      
  <img src="../../../img/favicon.ico" alt="logo">

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3zm0 5h18v2H3zm0 5h18v2H3z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Ohio SPBM Demo
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              Preferred Drug List
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="(prefers-color-scheme: light)" data-md-color-scheme="gainwell" data-md-color-primary="indigo" data-md-color-accent="indigo"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 6H7c-3.31 0-6 2.69-6 6s2.69 6 6 6h10c3.31 0 6-2.69 6-6s-2.69-6-6-6m0 10H7c-2.21 0-4-1.79-4-4s1.79-4 4-4h10c2.21 0 4 1.79 4 4s-1.79 4-4 4M7 9c-1.66 0-3 1.34-3 3s1.34 3 3 3 3-1.34 3-3-1.34-3-3-3"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="(prefers-color-scheme: dark)" data-md-color-scheme="slate" data-md-color-primary="indigo" data-md-color-accent="indigo"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 7H7a5 5 0 0 0-5 5 5 5 0 0 0 5 5h10a5 5 0 0 0 5-5 5 5 0 0 0-5-5m0 8a3 3 0 0 1-3-3 3 3 0 0 1 3-3 3 3 0 0 1 3 3 3 3 0 0 1-3 3"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var palette=__md_get("__palette");if(palette&&palette.color){if("(prefers-color-scheme)"===palette.color.media){var media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']");palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent")}for(var[key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      <label class="md-header__button md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.52 6.52 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5"/></svg>
      </label>
      <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.52 6.52 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12z"/></svg>
        </button>
      </nav>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" tabindex="0" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
    
    
      <div class="md-header__source">
        <a href="https://github.com/gainwell-ohio/spbm/" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512"><!--! Font Awesome Free 6.6.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc.--><path d="M439.55 236.05 244 40.45a28.87 28.87 0 0 0-40.81 0l-40.66 40.63 51.52 51.52c27.06-9.14 52.68 16.77 43.39 43.68l49.66 49.66c34.23-11.8 61.18 31 35.47 56.69-26.49 26.49-70.21-2.87-56-37.34L240.22 199v121.85c25.3 12.54 22.26 41.85 9.08 55a34.34 34.34 0 0 1-48.55 0c-17.57-17.6-11.07-46.91 11.25-56v-123c-20.8-8.51-24.6-30.74-18.64-45L142.57 101 8.45 235.14a28.86 28.86 0 0 0 0 40.81l195.61 195.6a28.86 28.86 0 0 0 40.8 0l194.69-194.69a28.86 28.86 0 0 0 0-40.81"/></svg>
  </div>
  <div class="md-source__repository">
    Evergreen
  </div>
</a>
      </div>
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
            
<nav class="md-tabs" aria-label="Tabs" data-md-component="tabs">
  <div class="md-grid">
    <ul class="md-tabs__list">
      
        
  
  
  
    <li class="md-tabs__item">
      <a href="../../.." class="md-tabs__link">
        
  
    
  
  Welcome

      </a>
    </li>
  

      
        
  
  
  
    
    
      <li class="md-tabs__item">
        <a href="../../../Clinical%20and%20Technical%20Reference%20Guide/peer_to_peer/" class="md-tabs__link">
          
  
  Clinical and Technical Reference Guide

        </a>
      </li>
    
  

      
        
  
  
  
    
    
      <li class="md-tabs__item">
        <a href="../../../Forms/decision_tree_forms/" class="md-tabs__link">
          
  
  Forms

        </a>
      </li>
    
  

      
        
  
  
  
    
    
      <li class="md-tabs__item">
        <a href="../../../Learning%20Materials/Access_and_Maintenance/" class="md-tabs__link">
          
  
  Learning Materials

        </a>
      </li>
    
  

      
        
  
  
  
    
    
      <li class="md-tabs__item">
        <a href="../../../Pharmacist%20Reference%20Guide/Links/" class="md-tabs__link">
          
  
  Pharmacist Reference Guide

        </a>
      </li>
    
  

      
        
  
  
    
  
  
    
    
      <li class="md-tabs__item md-tabs__item--active">
        <a href="../../medical_necessity_policy/" class="md-tabs__link">
          
  
  UPDL and Supporting Documents

        </a>
      </li>
    
  

      
        
  
  
  
    
    
      <li class="md-tabs__item">
        <a href="../../../Work%20Manager%20Resources/communication_strategies/" class="md-tabs__link">
          
  
  Work Manager Resources

        </a>
      </li>
    
  

      
        
  
  
  
    
    
      <li class="md-tabs__item">
        <a href="../../../about/About/" class="md-tabs__link">
          
  
  About

        </a>
      </li>
    
  

      
    </ul>
  </div>
</nav>
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    


  


<nav class="md-nav md-nav--primary md-nav--lifted" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href="../../.." title="Ohio SPBM Demo" class="md-nav__button md-logo" aria-label="Ohio SPBM Demo" data-md-component="logo">
      
  <img src="../../../img/favicon.ico" alt="logo">

    </a>
    Ohio SPBM Demo
  </label>
  
    <div class="md-nav__source">
      <a href="https://github.com/gainwell-ohio/spbm/" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512"><!--! Font Awesome Free 6.6.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc.--><path d="M439.55 236.05 244 40.45a28.87 28.87 0 0 0-40.81 0l-40.66 40.63 51.52 51.52c27.06-9.14 52.68 16.77 43.39 43.68l49.66 49.66c34.23-11.8 61.18 31 35.47 56.69-26.49 26.49-70.21-2.87-56-37.34L240.22 199v121.85c25.3 12.54 22.26 41.85 9.08 55a34.34 34.34 0 0 1-48.55 0c-17.57-17.6-11.07-46.91 11.25-56v-123c-20.8-8.51-24.6-30.74-18.64-45L142.57 101 8.45 235.14a28.86 28.86 0 0 0 0 40.81l195.61 195.6a28.86 28.86 0 0 0 40.8 0l194.69-194.69a28.86 28.86 0 0 0 0-40.81"/></svg>
  </div>
  <div class="md-source__repository">
    Evergreen
  </div>
</a>
    </div>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../../.." class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Welcome
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../../Clinical%20and%20Technical%20Reference%20Guide/peer_to_peer/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Clinical and Technical Reference Guide
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

    
      
      
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../../Forms/decision_tree_forms/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Forms
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

    
      
      
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../../Learning%20Materials/Access_and_Maintenance/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Learning Materials
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

    
      
      
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../../Pharmacist%20Reference%20Guide/Links/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Pharmacist Reference Guide
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

    
      
      
  
  
    
  
  
  
    
    
    
      
        
        
      
      
    
    
      
    
    <li class="md-nav__item md-nav__item--active md-nav__item--section md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_6" checked>
        
          
          <label class="md-nav__link" for="__nav_6" id="__nav_6_label" tabindex="">
            
  
  <span class="md-ellipsis">
    UPDL and Supporting Documents
  </span>
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_6_label" aria-expanded="true">
          <label class="md-nav__title" for="__nav_6">
            <span class="md-nav__icon md-icon"></span>
            UPDL and Supporting Documents
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../medical_necessity_policy/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Medical Necessity Policy and Procedures
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../otc_list/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    OTC List
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Analgesic_Agents/NSAIDs/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Analgesic Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../BloodFCT_Agents/colony_stimulating_factors/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    BloodFCT Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../CNS_Agents/alzheimers_agents/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    CNS Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Cardio_Agents/angina_hypertension/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Cardio Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Derma_Agents/oral_acne_products/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Derma Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Endocrine_Agents/androgens/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Endocrine Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Gastro_Agents/anti-emetics/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Gastro Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Genitourinary_Agents/benign_prostatic_hyperplasia/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Genitourinary Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Immuno_Agents/systematic_inflammatory/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Immuno Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Infectious_Disease_Agents/antifungals/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Infectious Disease Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Ophthalmic_Agents/NSAIDs/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Ophthalmic Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Otic_Agents/antibacterial/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Otic Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Respiratory_Agents/antihistamines/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Respiratory Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
    
  
  
  
    
    
    
      
      
    
    
      
    
    <li class="md-nav__item md-nav__item--active md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_6_16" checked>
        
          
          <label class="md-nav__link" for="__nav_6_16" id="__nav_6_16_label" tabindex="0">
            
  
  <span class="md-ellipsis">
    Supporting Documents
  </span>
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_6_16_label" aria-expanded="true">
          <label class="md-nav__title" for="__nav_6_16">
            <span class="md-nav__icon md-icon"></span>
            Supporting Documents
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Index
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../UPDL_criteria/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    UPDL Criteria
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../additional_therapeutic/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Additional Therapeutic Classes with Clinical Criteria
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../payable_active_ingredients/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Payable Active Pharmaceutical Compounding Ingredients and Excipients
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
    
  
  
  
    <li class="md-nav__item md-nav__item--active">
      
      <input class="md-nav__toggle md-toggle" type="checkbox" id="__toc">
      
      
        
      
      
        <label class="md-nav__link md-nav__link--active" for="__toc">
          
  
  <span class="md-ellipsis">
    Preferred Drug List
  </span>
  

          <span class="md-nav__icon md-icon"></span>
        </label>
      
      <a href="./" class="md-nav__link md-nav__link--active">
        
  
  <span class="md-ellipsis">
    Preferred Drug List
  </span>
  

      </a>
      
        

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
    
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon"></span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-component="toc" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#analgesic_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Analgesic Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#blood_formation_coagulation_and_thrombosis_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Blood Formation, Coagulation, and Thrombosis Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#cardiovascular_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Cardiovascular Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#central_nervous_system_cns_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Central Nervous System (CNS) Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#dermatological_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Dermatological Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#endocrine_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Endocrine Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#gastrointestinal_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Gastrointestinal Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#genitourinary_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Genitourinary Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#immunomodulator_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Immunomodulator Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#infectious_disease_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Infectious Disease Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#ophthalmic_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Ophthalmic Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#otic_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Otic Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#respiratory_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Respiratory Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#topical_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Topical Agents
    </span>
  </a>
  
</li>
      
    </ul>
  
</nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../quantity/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Quantity Limit List
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../specialty_drug_list/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Specialty Drug List by Therapeutic Class
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../supply_list/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Supply list
  </span>
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Topical_Agents/antifungal/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Topical Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../ePA%20Question%20Sets/BloodBlood%20Products%20Hematopoietic%20Agents/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    ePA Question Sets
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
      
      
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../../Work%20Manager%20Resources/communication_strategies/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Work Manager Resources
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

    
      
      
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../../about/About/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    About
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
    
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon"></span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-component="toc" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#analgesic_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Analgesic Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#blood_formation_coagulation_and_thrombosis_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Blood Formation, Coagulation, and Thrombosis Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#cardiovascular_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Cardiovascular Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#central_nervous_system_cns_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Central Nervous System (CNS) Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#dermatological_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Dermatological Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#endocrine_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Endocrine Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#gastrointestinal_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Gastrointestinal Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#genitourinary_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Genitourinary Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#immunomodulator_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Immunomodulator Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#infectious_disease_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Infectious Disease Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#ophthalmic_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Ophthalmic Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#otic_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Otic Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#respiratory_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Respiratory Agents
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#topical_agents" class="md-nav__link">
    <span class="md-ellipsis">
      Topical Agents
    </span>
  </a>
  
</li>
      
    </ul>
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
            <div class="md-content" data-md-component="content">
              <article class="md-content__inner md-typeset">
                
                  

  
    <a href="https://github.com/gainwell-ohio/spbm/edit/main/docs/UPDL and Supporting Documents/Supporting Documents/preferred_drug_list.md" title="Edit this page" class="md-content__button md-icon">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20.71 7.04c.39-.39.39-1.04 0-1.41l-2.34-2.34c-.37-.39-1.02-.39-1.41 0l-1.84 1.83 3.75 3.75M3 17.25V21h3.75L17.81 9.93l-3.75-3.75z"/></svg>
    </a>
  
  


<h1 id="preferred_drug_list">Preferred Drug List<a class="headerlink" href="#preferred_drug_list" title="Permanent link">&para;</a></h1>
<h2 id="analgesic_agents">Analgesic Agents<a class="headerlink" href="#analgesic_agents" title="Permanent link">&para;</a></h2>
<p><strong>Gout</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Allopurinol 100mg, 300mg <sup>QL</sup></td>
<td>Allopurinol 200mg</td>
</tr>
<tr>
<td>Colchicine Tab <sup>PA QL</sup></td>
<td>Mitigare <sup>BvG QL</sup></td>
</tr>
<tr>
<td>Colcrys Tab <sup>PA QL</sup></td>
<td>Febuxostat</td>
</tr>
<tr>
<td>Probenecid <sup>QL</sup></td>
<td>Gloperba Susp <sup>QL</sup></td>
</tr>
<tr>
<td></td>
<td>Probenecid/Colchicine <sup>QL</sup></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=8" rel="noopener">Link to Criteria: Analgesic Agents: Gout</a></p>
<p><strong>NSAIDS</strong>    </p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Celecoxib <sup>QL</sup></td>
<td>Diclofenac/Misoprostol</td>
</tr>
<tr>
<td>Diclofenac IR, DR, ER, Gel 1%</td>
<td>Diclofenac Gel 3%, Patch 1.3%, Soln 2%</td>
</tr>
<tr>
<td>Etodolac</td>
<td>Diclotrex</td>
</tr>
<tr>
<td>Fenoprofen 600 MG</td>
<td>Elyxyb</td>
</tr>
<tr>
<td>Flurbiprofen</td>
<td>Fenoprofen 400 MG</td>
</tr>
<tr>
<td>Ibuprofen</td>
<td>Ibuprofen/Famotidine</td>
</tr>
<tr>
<td>Indocin</td>
<td>Ketorolac Tromethamine Nasal Spray</td>
</tr>
<tr>
<td>Indomethacin</td>
<td>Ketoprofen</td>
</tr>
<tr>
<td>Ketoprofen ER</td>
<td>Licart Patch</td>
</tr>
<tr>
<td>Ketorolac</td>
<td>Meloxicam Cap</td>
</tr>
<tr>
<td>Meclofenamate</td>
<td>Naproxen CR, DR, ER, EC</td>
</tr>
<tr>
<td>Mefenamic Acid</td>
<td>Naproxen/Esomeprazole</td>
</tr>
<tr>
<td>Meloxicam Tab</td>
<td>Pennsaid <sup>BvG</sup></td>
</tr>
<tr>
<td>Nabumetone</td>
<td>Qmiiz ODT</td>
</tr>
<tr>
<td>Naproxen IR</td>
<td>Relafen DS</td>
</tr>
<tr>
<td>Naproxen Susp <sup>AR</sup></td>
<td>Zorvolex</td>
</tr>
<tr>
<td>Oxaprozin</td>
<td></td>
</tr>
<tr>
<td>Piroxicam</td>
<td></td>
</tr>
<tr>
<td>Sulindac</td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=9" rel="noopener">Link to Criteria: Analgesic Agents: NSAIDS</a></p>
<p><strong>Opioids</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Acetaminophen/Codeine <sup>QL</sup></td>
<td>Acetaminophen/Caffeine/Dihydrocodeine <sup>QL</sup></td>
</tr>
<tr>
<td>Butalbital/Acetaminophen/Caffeine/Codeine <sup>QL</sup></td>
<td>Belbuca <sup>QL</sup></td>
</tr>
<tr>
<td>Butalbital/Aspirin/Caffeine/Codeine <sup>QL</sup></td>
<td>Benzhydrocodone/Acetaminophen <sup>QL</sup></td>
</tr>
<tr>
<td>Butorphanol <sup>QL</sup></td>
<td>Buprenorphine TD Patch Weekly <sup>QL</sup></td>
</tr>
<tr>
<td>Butrans <sup>BvG PA QL</sup></td>
<td>Butalbital/Acetaminophen/Caffeine/Codeine 50/300/40/30mg <sup>QL</sup></td>
</tr>
<tr>
<td>Codeine <sup>QL</sup></td>
<td>Dsuvia <sup>QL</sup></td>
</tr>
<tr>
<td>Hydrocodone/Acetaminophen <sup>QL</sup></td>
<td>Fentanyl <sup>QL</sup></td>
</tr>
<tr>
<td>Hydromorphone IR <sup>QL</sup></td>
<td>Hydrocodone Bitartrate ER 12HR Cap <sup>QL</sup></td>
</tr>
<tr>
<td>Morphine IR Tab, Sol <sup>QL</sup></td>
<td>Hydrocodone Bitartrate ER 24HR Tab <sup>QL</sup></td>
</tr>
<tr>
<td>Morphine ER Tab <sup>PA QL</sup></td>
<td>Hydrocodone/Acetaminophen 5-300, 7.5-300, 10-300 MG <sup>QL</sup></td>
</tr>
<tr>
<td>Nucynta IR <sup>QL</sup></td>
<td>Hydrocodone/Ibuprofen <sup>QL</sup></td>
</tr>
<tr>
<td>Nucynta ER <sup>PA QL</sup></td>
<td>Hydromorphone ER <sup>QL</sup></td>
</tr>
<tr>
<td>Oxycodone Cap, Sol, Tab <sup>QL</sup></td>
<td>Levorphanol <sup>QL</sup></td>
</tr>
<tr>
<td>Oxycodone/Acetaminophen <sup>QL</sup></td>
<td>Meperidine <sup>QL</sup></td>
</tr>
<tr>
<td>Tramadol <sup>QL</sup></td>
<td>Methadone <sup>QL</sup></td>
</tr>
<tr>
<td>Tramadol/Acetaminophen <sup>QL</sup></td>
<td>Morphine ER 24HR Cap <sup>QL</sup></td>
</tr>
<tr>
<td></td>
<td>Oxycodone ER <sup>QL</sup></td>
</tr>
<tr>
<td></td>
<td>Oxycodone/Ibuprofen <sup>QL</sup></td>
</tr>
<tr>
<td></td>
<td>Oxymorphone IR, ER <sup>QL</sup></td>
</tr>
<tr>
<td></td>
<td>Pentazocine/Naloxone <sup>QL</sup></td>
</tr>
<tr>
<td></td>
<td>Seglentis <sup>QL</sup></td>
</tr>
<tr>
<td></td>
<td>Tramadol ER, Sol <sup>QL</sup></td>
</tr>
<tr>
<td></td>
<td>Xtampza ER <sup>QL</sup></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=10" rel="noopener">Link to Criteria: Analgesic Agents: Opioids</a></p>
<h2 id="blood_formation_coagulation_and_thrombosis_agents">Blood Formation, Coagulation, and Thrombosis Agents<a class="headerlink" href="#blood_formation_coagulation_and_thrombosis_agents" title="Permanent link">&para;</a></h2>
<p><strong>Colony Stimulating Factors</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Neupogen <sup>PA</sup></td>
<td>Fulphila</td>
</tr>
<tr>
<td>Nivestym <sup>PA</sup></td>
<td>Fylnetra</td>
</tr>
<tr>
<td>Nyvepria <sup>PA</sup></td>
<td>Granix</td>
</tr>
<tr>
<td>Ziextenzo <sup>PA</sup></td>
<td>Leukine</td>
</tr>
<tr>
<td></td>
<td>Neulasta</td>
</tr>
<tr>
<td></td>
<td>Releuko</td>
</tr>
<tr>
<td></td>
<td>Rolvedon</td>
</tr>
<tr>
<td></td>
<td>Stimufend</td>
</tr>
<tr>
<td></td>
<td>Udenyca</td>
</tr>
<tr>
<td></td>
<td>Zarxio</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=13" rel="noopener">Link to Criteria: Blood Formation, Coagulation, and Thrombosis Agents: Colony Stimulating Factors</a></p>
<p><strong>Hematopoietic Agents</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Epogen <sup>PA</sup></td>
<td>Aranesp</td>
</tr>
<tr>
<td>Mircera <sup>PA</sup></td>
<td>Procrit</td>
</tr>
<tr>
<td>Retacrit <sup>PA</sup></td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=14" rel="noopener">Link to Criteria: Blood Formation, Coagulation, and Thrombosis Agents: Hematopoietic Agents</a></p>
<p><strong>Hemophilia Factor</strong>*</p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Advate <sup>PA</sup></td>
<td>Jivi</td>
</tr>
<tr>
<td>Adynovate <sup>PA</sup></td>
<td>Nuwiq</td>
</tr>
<tr>
<td>Afstyla <sup>PA</sup></td>
<td>Obizur</td>
</tr>
<tr>
<td>Alphanate <sup>PA</sup></td>
<td>Rebinyn</td>
</tr>
<tr>
<td>Alphanine SD <sup>PA</sup></td>
<td>Sevenfact</td>
</tr>
<tr>
<td>Alprolix <sup>PA</sup></td>
<td>Vonvendi</td>
</tr>
<tr>
<td>Benefix <sup>PA</sup></td>
<td></td>
</tr>
<tr>
<td>Corifact <sup>PA</sup></td>
<td></td>
</tr>
<tr>
<td>Eloctate <sup>PA</sup></td>
<td></td>
</tr>
<tr>
<td>Esperoct <sup>PA</sup></td>
<td></td>
</tr>
<tr>
<td>Feiba <sup>PA</sup></td>
<td></td>
</tr>
<tr>
<td>Hemlibra <sup>PA</sup></td>
<td></td>
</tr>
<tr>
<td>Hemofil M <sup>PA</sup></td>
<td></td>
</tr>
<tr>
<td>Humate-P <sup>PA</sup></td>
<td></td>
</tr>
<tr>
<td>Idelvion <sup>PA</sup></td>
<td></td>
</tr>
<tr>
<td>Ixinity <sup>PA</sup></td>
<td></td>
</tr>
<tr>
<td>Koate <sup>PA</sup></td>
<td></td>
</tr>
<tr>
<td>Kogenate FS <sup>PA</sup></td>
<td></td>
</tr>
<tr>
<td>Kovaltry <sup>PA</sup></td>
<td></td>
</tr>
<tr>
<td>Mononine <sup>PA</sup></td>
<td></td>
</tr>
<tr>
<td>Novoeight <sup>PA</sup></td>
<td></td>
</tr>
<tr>
<td>Novoseven RT <sup>PA</sup></td>
<td></td>
</tr>
<tr>
<td>Profilnine <sup>PA</sup></td>
<td></td>
</tr>
<tr>
<td>Recombinate <sup>PA</sup></td>
<td></td>
</tr>
<tr>
<td>Rixubis <sup>PA</sup></td>
<td></td>
</tr>
<tr>
<td>Wilate <sup>PA</sup></td>
<td></td>
</tr>
<tr>
<td>Xyntha <sup>PA</sup></td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=15" rel="noopener">Link to Criteria: Blood Formation, Coagulation, and Thrombosis Agents: Hemophilia Factors</a></p>
<p><strong>Heparin-Related Preparations</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Enoxaparin</td>
<td>Fondaparinux</td>
</tr>
<tr>
<td></td>
<td>Fragmin</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=16" rel="noopener">Link to Criteria: Blood Formation, Coagulation, and Thrombosis Agents: Heparin-Related Preparations</a></p>
<p><strong>Oral Anticoagulants</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Eliquis</td>
<td>Dabigatran</td>
</tr>
<tr>
<td>Pradaxa <sup>BvG</sup></td>
<td>Savaysa</td>
</tr>
<tr>
<td>Warfarin</td>
<td>Xarelto Susp</td>
</tr>
<tr>
<td>Xarelto Tab <sup>QL</sup></td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=17" rel="noopener">Link to Criteria: Blood Formation, Coagulation, and Thrombosis Agents: Oral Anticoagulants</a></p>
<p><strong>Oral Antiplatelet</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Aspirin</td>
<td>Yosprala</td>
</tr>
<tr>
<td>Aspirin/Dipyridamole ER</td>
<td>Zontivity</td>
</tr>
<tr>
<td>Brilinta</td>
<td></td>
</tr>
<tr>
<td>Clopidogrel</td>
<td></td>
</tr>
<tr>
<td>Prasugrel <sup>QL</sup></td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=18" rel="noopener">Link to Criteria: Blood Formation, Coagulation, and Thrombosis Agents: Oral Antiplatelet</a></p>
<h2 id="cardiovascular_agents">Cardiovascular Agents<a class="headerlink" href="#cardiovascular_agents" title="Permanent link">&para;</a></h2>
<p><strong>Angina, Hypertension and Heart Failure</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Acebutolol <sup>QL</sup></td>
<td>Aliskiren</td>
</tr>
<tr>
<td>Amlodipine <sup>QL</sup></td>
<td>Aspruzyo Sprinkle</td>
</tr>
<tr>
<td>Amlodipine/Benazepril</td>
<td>Camzyos</td>
</tr>
<tr>
<td>Amlodipine/Olmesartan <sup>QL</sup></td>
<td>Candesartan</td>
</tr>
<tr>
<td>Amlodipine/Valsartan</td>
<td>Candesartan/HCTZ</td>
</tr>
<tr>
<td>Amlodipine/Valsartan/HCTZ</td>
<td>Carospir</td>
</tr>
<tr>
<td>Atenolol <sup>QL</sup></td>
<td>Carvedilol ER</td>
</tr>
<tr>
<td>Atenolol/Chlorthalidone</td>
<td>Clonidine ER (generic of Nexiclon XR)</td>
</tr>
<tr>
<td>Benazepril</td>
<td>Corlanor</td>
</tr>
<tr>
<td>Benazepril/HCTZ</td>
<td>Diltiazem 24 HR ER Tabs <sup>QL</sup></td>
</tr>
<tr>
<td>Betaxolol <sup>QL</sup></td>
<td>Edarbi</td>
</tr>
<tr>
<td>Bisoprolol <sup>QL</sup></td>
<td>Edarbyclor</td>
</tr>
<tr>
<td>Bisoprolol/HCTZ</td>
<td>Hydralazine/HCTZ</td>
</tr>
<tr>
<td>Bystolic <sup>BvG</sup></td>
<td>Innopran XL</td>
</tr>
<tr>
<td>Captopril</td>
<td>Isradipine</td>
</tr>
<tr>
<td>Captopril/HCTZ</td>
<td>Kapspargo</td>
</tr>
<tr>
<td>Cartia XT</td>
<td>Katerzia</td>
</tr>
<tr>
<td>Carvedilol <sup>QL</sup></td>
<td>Kerendia</td>
</tr>
<tr>
<td>Clonidine IR, Patch</td>
<td>Levamlodipine</td>
</tr>
<tr>
<td>Diltiazem <sup>QL</sup></td>
<td>Nebivolol</td>
</tr>
<tr>
<td>Diltiazem 12HR ER Cap <sup>QL</sup></td>
<td>Nimodipine</td>
</tr>
<tr>
<td>Diltiazem 24HR ER Cap <sup>QL</sup></td>
<td>Nisoldipine</td>
</tr>
<tr>
<td>Doxazosin</td>
<td>Norliqva</td>
</tr>
<tr>
<td>Dutoprol</td>
<td>Nymalize</td>
</tr>
<tr>
<td>Enalapril Tab</td>
<td>Qbrelis</td>
</tr>
<tr>
<td>Enalapril/HCTZ</td>
<td>Sotylize <sup>AR</sup></td>
</tr>
<tr>
<td>Entresto <sup>PA</sup></td>
<td>Tekturna/HCTZ</td>
</tr>
<tr>
<td>Enalapril Sol</td>
<td>Telmisartan</td>
</tr>
<tr>
<td>Eplerenone</td>
<td>Telmisartan/HCTZ</td>
</tr>
<tr>
<td>Felodipine ER <sup>QL</sup></td>
<td>Verapamil 200, 300mg ER 24 HR <sup>QL</sup></td>
</tr>
<tr>
<td>Fosinopril</td>
<td>Verquvo</td>
</tr>
<tr>
<td>Fosinopril/HCTZ</td>
<td></td>
</tr>
<tr>
<td>Guanfacine</td>
<td></td>
</tr>
<tr>
<td>Hemangeol <sup>PA</sup></td>
<td></td>
</tr>
<tr>
<td>Hydralazine</td>
<td></td>
</tr>
<tr>
<td>Irbesartan <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Irbesartan/HCTZ <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Labetalol <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Lisinopril</td>
<td></td>
</tr>
<tr>
<td>Lisinopril/HCTZ</td>
<td></td>
</tr>
<tr>
<td>Losartan <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Losartan/HCTZ</td>
<td></td>
</tr>
<tr>
<td>Olmesartan</td>
<td></td>
</tr>
<tr>
<td>Olmesartan/Amlodipine/HCTZ</td>
<td></td>
</tr>
<tr>
<td>Olmesartan/HCTZ</td>
<td></td>
</tr>
<tr>
<td>Methyldopa</td>
<td></td>
</tr>
<tr>
<td>Methyldopa/HCTZ</td>
<td></td>
</tr>
<tr>
<td>Metoprolol Succinate <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Metoprolol Tartrate <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Metoprolol/HCTZ <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Minoxidil</td>
<td></td>
</tr>
<tr>
<td>Moexipril</td>
<td></td>
</tr>
<tr>
<td>Nadolol <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Nadolol/Bendroflumethiazide</td>
<td></td>
</tr>
<tr>
<td>Nicardipine <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Nifedipine <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Perindopril</td>
<td></td>
</tr>
<tr>
<td>Pindolol <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Prazosin</td>
<td></td>
</tr>
<tr>
<td>Propranolol</td>
<td></td>
</tr>
<tr>
<td>Propranolol/HCTZ</td>
<td></td>
</tr>
<tr>
<td>Quinapril</td>
<td></td>
</tr>
<tr>
<td>Quinapril/HCTZ</td>
<td></td>
</tr>
<tr>
<td>Ramipril</td>
<td></td>
</tr>
<tr>
<td>Ranolazine</td>
<td></td>
</tr>
<tr>
<td>Sotalol <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Spironolactone</td>
<td></td>
</tr>
<tr>
<td>Spironolactone/HCTZ</td>
<td></td>
</tr>
<tr>
<td>Telmisartan/Amlodipine</td>
<td></td>
</tr>
<tr>
<td>Terazosin</td>
<td></td>
</tr>
<tr>
<td>Timolol <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Trandolapril</td>
<td></td>
</tr>
<tr>
<td>Trandolapril/Verapamil</td>
<td></td>
</tr>
<tr>
<td>Valsartan <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Valsartan/HCTZ <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Verapamil IR, SR <sup>QL</sup></td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=19" rel="noopener">Link to Criteria: Cardiovascular Agents: Angina, Hypertension &amp; Heart Failure</a></p>
<p><strong>Antiarrhythmics</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Amiodarone 200 MG <sup>QL</sup></td>
<td>Amiodarone 100 MG, 400 MG <sup>QL</sup></td>
</tr>
<tr>
<td>Disopyramide <sup>QL</sup></td>
<td>Multaq</td>
</tr>
<tr>
<td>Dofetilide</td>
<td></td>
</tr>
<tr>
<td>Flecainide <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Mexiletine <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Norpace CR <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Propafenone IR, ER <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Quinidine IR, ER <sup>QL</sup></td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=21" rel="noopener">Link to Criteria: Cardiovascular Agents: Antiarrhythmics</a></p>
<p><strong>Lipotropics</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Atorvastatin <sup>QL</sup></td>
<td>Altoprev</td>
</tr>
<tr>
<td>Cholestyramine Regular, Light</td>
<td>Amlodipine/Atorvastatin</td>
</tr>
<tr>
<td>Colestipol Tab</td>
<td>Colesevelam</td>
</tr>
<tr>
<td>Ezetimibe</td>
<td>Colestipol Granules</td>
</tr>
<tr>
<td>Fenofibrate 48, 145mg Tab <sup>QL</sup></td>
<td>Ezetimibe/Simvastatin</td>
</tr>
<tr>
<td>Gemfibrozil <sup>QL</sup></td>
<td>Ezallor</td>
</tr>
<tr>
<td>Lovastatin <sup>QL</sup></td>
<td>Fenofibrate Cap <sup>QL</sup></td>
</tr>
<tr>
<td>Omega-3-Acid Ethyl Esters</td>
<td>Fenofibrate 40, 54, 120, 160mg Tab <sup>QL</sup></td>
</tr>
<tr>
<td>Niacin IR, ER OTC <sup>QL</sup></td>
<td>Fenofibric Acid <sup>QL</sup></td>
</tr>
<tr>
<td>Praluent <sup>PA</sup></td>
<td>Fluvastatin</td>
</tr>
<tr>
<td>Pravastatin</td>
<td>Juxtapid</td>
</tr>
<tr>
<td>Prevalite</td>
<td>Livalo</td>
</tr>
<tr>
<td>Repatha <sup>PA</sup></td>
<td>Nexletol</td>
</tr>
<tr>
<td>Rosuvastatin <sup>QL</sup></td>
<td>Nexlizet</td>
</tr>
<tr>
<td>Simvastatin <sup>QL</sup></td>
<td>Niacin ER Tab <sup>QL</sup></td>
</tr>
<tr>
<td></td>
<td>Vascepa <sup>BvG</sup></td>
</tr>
<tr>
<td></td>
<td>Zypitamag</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=22" rel="noopener">Link to Criteria: Cardiovascular Agents: Lipotropics</a></p>
<p><strong>Pulmonary Arterial Hypertension</strong>*</p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ambrisentan <sup>PA</sup></td>
<td>Adempas</td>
</tr>
<tr>
<td>Sildenafil <sup>PA</sup></td>
<td>Bosentan</td>
</tr>
<tr>
<td>Sildenafil Susp <sup>AR PA</sup></td>
<td>Epoprostenol</td>
</tr>
<tr>
<td>Tadalafil <sup>PA</sup></td>
<td>Opsumit</td>
</tr>
<tr>
<td>Tadliq <sup>AR PA</sup></td>
<td>Tracleer Susp</td>
</tr>
<tr>
<td>Tracleer Tab <sup>BvG PA</sup></td>
<td>Treprostinil</td>
</tr>
<tr>
<td></td>
<td>Tyvaso</td>
</tr>
<tr>
<td></td>
<td>Uptravi</td>
</tr>
<tr>
<td></td>
<td>Ventavis</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=24" rel="noopener">Link to Criteria: Cardiovascular Agents: Pulmonary Arterial Hypertension</a></p>
<h2 id="central_nervous_system_cns_agents">Central Nervous System (CNS) Agents<a class="headerlink" href="#central_nervous_system_cns_agents" title="Permanent link">&para;</a></h2>
<p><strong>Alzheimer's Agents</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Donepezil 5mg, 10mg Tab <sup>AR QL</sup></td>
<td>Adlarity <sup>AR</sup></td>
</tr>
<tr>
<td>Donepezil ODT <sup>AR QL</sup></td>
<td>Donepezil 23mg Tab <sup>AR QL</sup></td>
</tr>
<tr>
<td>Exelon Patch <sup>AR BvG</sup></td>
<td>Galantamine Sol <sup>AR QL</sup></td>
</tr>
<tr>
<td>Galantamine IR Tab, ER Cap <sup>AR QL</sup></td>
<td>Memantine ER, Sol <sup>AR</sup></td>
</tr>
<tr>
<td>Memantine Tab <sup>AR</sup></td>
<td>Namzaric <sup>AR</sup></td>
</tr>
<tr>
<td>Rivastigmine Cap <sup>AR QL</sup></td>
<td></td>
</tr>
<tr>
<td>Rivastigmine Patch <sup>AR</sup></td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=25" rel="noopener">Link to Criteria: Central Nervous System (CNS) Agents: Alzheimer's Agents</a></p>
<p><strong>Anti-Migraine Agents, Acute</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Imitrex Nasal Spray <sup>BvG QL</sup></td>
<td>Almotriptan</td>
</tr>
<tr>
<td>Naratriptan <sup>QL</sup></td>
<td>Dihydroergotamine</td>
</tr>
<tr>
<td>Nurtec ODT <sup>QL ST</sup></td>
<td>Eletriptan</td>
</tr>
<tr>
<td>Rizatriptan <sup>QL</sup></td>
<td>Ergomar</td>
</tr>
<tr>
<td>Sumatriptan Inj, Tab <sup>QL</sup></td>
<td>Frovatriptan</td>
</tr>
<tr>
<td>Tosymra <sup>BvG QL</sup></td>
<td>Migergot</td>
</tr>
<tr>
<td></td>
<td>Onzetra Xsail <sup>QL</sup></td>
</tr>
<tr>
<td></td>
<td>Reyvow</td>
</tr>
<tr>
<td></td>
<td>Sumatriptan/Naproxen</td>
</tr>
<tr>
<td></td>
<td>Sumatriptan Nasal Spray <sup>QL</sup></td>
</tr>
<tr>
<td></td>
<td>Trudhesa</td>
</tr>
<tr>
<td></td>
<td>Ubrelvy</td>
</tr>
<tr>
<td></td>
<td>Zolmitriptan</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=26" rel="noopener">Link to Criteria: Central Nervous System (CNS) Agents: Anti-Migraine Agents, Acute</a></p>
<p><strong>Anti-Migraine Agents, Cluster Headache</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Verapamil <sup>QL</sup></td>
<td>Emgality <sup>QL</sup></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=27" rel="noopener">Link to Criteria: Central Nervous System (CNS) Agents: Anti-Migraine Agents, Cluster Headache</a></p>
<p><strong>Anti-Migraine Agents, Prophylaxis</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Aimovig <sup>QL ST</sup></td>
<td>Emgality <sup>QL</sup></td>
</tr>
<tr>
<td>Ajovy <sup>QL ST</sup></td>
<td>Nurtec ODT <sup>QL</sup></td>
</tr>
<tr>
<td>Cardiovascular Agents: Beta-Blockers</td>
<td>Qulipta <sup>QL</sup></td>
</tr>
<tr>
<td>CNS Agents: Anticonvulsants</td>
<td></td>
</tr>
<tr>
<td>CNS Agents: Serotonin-Norepinephrine Reuptake Inhibitors</td>
<td></td>
</tr>
<tr>
<td>CNS Agents: Tricyclic Antidepressants</td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=28" rel="noopener">Link to Criteria: Central Nervous System (CNS) Agents: Anti-Migraine Agents, Prophylaxis</a></p>
<p><strong>Anticonvulsants</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Banzel Tab <sup>BvG</sup></td>
<td>Aptiom</td>
</tr>
<tr>
<td>Carbamazepine</td>
<td>Briviact</td>
</tr>
<tr>
<td>Clobazam</td>
<td>Celontin</td>
</tr>
<tr>
<td>Clonazepam</td>
<td>Clonazepam ODT</td>
</tr>
<tr>
<td>Diacomit <sup> PA QL</sup></td>
<td>Elepsia XR</td>
</tr>
<tr>
<td>Divalproex IR, ER</td>
<td>Felbamate</td>
</tr>
<tr>
<td>Epidiolex <sup>ST QL</sup></td>
<td>Fintepla</td>
</tr>
<tr>
<td>Eprontia <sup>AR</sup></td>
<td>Lamotrigine ER</td>
</tr>
<tr>
<td>Ethosuximide</td>
<td>Levetiracetam ER Tab</td>
</tr>
<tr>
<td>Fycompa <sup>ST</sup></td>
<td>Oxcarbazepine Susp</td>
</tr>
<tr>
<td>Gabapentin <sup>QL</sup></td>
<td>Oxtellar XR</td>
</tr>
<tr>
<td>Lamotrigine IR, ODT</td>
<td>Qudexy XR <sup>BvG</sup></td>
</tr>
<tr>
<td>Levetiracetam IR Tab, Sol</td>
<td>Peganone</td>
</tr>
<tr>
<td>Oxcarbazepine Tab</td>
<td>Rufinamide Tab, Soln</td>
</tr>
<tr>
<td>Phenobarbital</td>
<td>Spritam</td>
</tr>
<tr>
<td>Phenytoin</td>
<td>Sympazan</td>
</tr>
<tr>
<td>Pregabalin <sup>QL</sup></td>
<td>Tiagabine</td>
</tr>
<tr>
<td>Primidone</td>
<td>Topiramate Sprinkle Cap</td>
</tr>
<tr>
<td>Topiramate</td>
<td>Trokendi XR <sup>BvG</sup></td>
</tr>
<tr>
<td>Trileptal Susp <sup>BvG</sup></td>
<td>Vigabatrin</td>
</tr>
<tr>
<td>Valproic Acid</td>
<td>Vigabatrin Powder <sup>AR</sup></td>
</tr>
<tr>
<td>Lacosamide <sup>ST</sup></td>
<td>Xcopri</td>
</tr>
<tr>
<td>Zonisamide Cap</td>
<td>Zonisade Susp</td>
</tr>
<tr>
<td></td>
<td>Ztalmy</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=30" rel="noopener">Link to Criteria: Central Nervous System (CNS) Agents: Anticonvulsants</a></p>
<p><strong>Anticonvulsants Rescue</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Diastat</td>
<td></td>
</tr>
<tr>
<td>Diazempan Gel</td>
<td></td>
</tr>
<tr>
<td>Nayzilam <sup>AR</sup></td>
<td></td>
</tr>
<tr>
<td>Valtoco <sup>AR</sup></td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=32" rel="noopener">Link to Criteria: Central Nervous System (CNS) Agents: Anticonvulsants Rescue</a></p>
<p><strong>Antidepressants</strong>*</p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Bupropion <sup>QL</sup></td>
<td>Aplenzin</td>
</tr>
<tr>
<td>Bupropion SR (generic of Wellbutrin SR) <sup>QL</sup></td>
<td>Auvelity</td>
</tr>
<tr>
<td>Bupropion XL (generic of Wellbutrin XL) <sup>QL</sup></td>
<td>Brisdelle</td>
</tr>
<tr>
<td>Citalopram <sup>QL</sup></td>
<td>Bupropion XL (generic of Forfivo XL) <sup>QL</sup></td>
</tr>
<tr>
<td>Duloxetine 20, 30, 60 MG <sup>QL</sup></td>
<td>Clomipramine</td>
</tr>
<tr>
<td>Escitalopram <sup>QL</sup></td>
<td>Desvenlafaxine</td>
</tr>
<tr>
<td>Fluoxetine 10, 20, 40mg <sup>QL</sup></td>
<td>Drizalma Sprinkle</td>
</tr>
<tr>
<td>Fluoxetine Sol <sup>QL</sup></td>
<td>Duloxetine 40mg <sup>QL</sup></td>
</tr>
<tr>
<td>Fluvoxamine <sup>QL</sup></td>
<td>Emsam</td>
</tr>
<tr>
<td>Mirtazapine <sup>QL</sup></td>
<td>Fetzima</td>
</tr>
<tr>
<td>Nefazodone <sup>QL</sup></td>
<td>Fluoxetine 60mg, DR <sup>QL</sup></td>
</tr>
<tr>
<td>Paroxetine IR Tab, Sol <sup>QL</sup></td>
<td>Fluvoxamine ER <sup>QL</sup></td>
</tr>
<tr>
<td>Sertraline</td>
<td>Marplan</td>
</tr>
<tr>
<td>Tranylcypromine</td>
<td>Paroxetine Cap, ER Tab</td>
</tr>
<tr>
<td>Trazodone 50, 100, 150mg <sup>QL</sup></td>
<td>Pexeva</td>
</tr>
<tr>
<td>Venlafaxine IR Tab, ER Cap <sup>QL</sup></td>
<td>Phenelzine</td>
</tr>
<tr>
<td></td>
<td>Trazodone 300mg <sup>QL</sup></td>
</tr>
<tr>
<td></td>
<td>Trintellix</td>
</tr>
<tr>
<td></td>
<td>Venlafaxine ER Tab</td>
</tr>
<tr>
<td></td>
<td>Viibryd <sup>BvG</sup></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=33" rel="noopener">Link to Criteria: Central Nervous System (CNS) Agents: Antidepressants</a></p>
<p><strong>Attention Deficit Hyperactivity Disorder Agents</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Amphetamine/Dextroamphetamine IR, ER <sup>AR QL</sup></td>
<td>Adhansia XR <sup>AR</sup></td>
</tr>
<tr>
<td>Atomxetine Cap <sup>AR QL</sup></td>
<td>Adzenys ER, XR ODT</td>
</tr>
<tr>
<td>Clonidine ER</td>
<td>Amphetamine Tab</td>
</tr>
<tr>
<td>Concerta <sup>AR QL</sup></td>
<td>Azstarys <sup>AR</sup></td>
</tr>
<tr>
<td>Dexmethylphenidate ER (generic of Focalin XR) <sup>AR QL</sup></td>
<td>Daytrana <sup>AR BvG</sup></td>
</tr>
<tr>
<td>Dextroamphetamine IR Tab, ER Cap <sup>AR QL</sup></td>
<td>Evekeo ODT</td>
</tr>
<tr>
<td>Dextroamphetamine Sol <sup>AR</sup></td>
<td>Jornay PM <sup>AR</sup></td>
</tr>
<tr>
<td>Dyanavel XR <sup>AR</sup></td>
<td>Methamphetamine</td>
</tr>
<tr>
<td>Guanfacine ER <sup>QL</sup></td>
<td>Methylphenidate Chewable Tab <sup>AR QL</sup></td>
</tr>
<tr>
<td>Methylphenidate ER Cap <sup>AR QL</sup> (generic of Metadate CD, Ritalin LA)</td>
<td>Methylphenidate ER <sup>AR QL</sup> (generic of Aptensio XR, Relexxii)</td>
</tr>
<tr>
<td>Methylphenidate ER Tab <sup>AR QL</sup> (generic of Concerta, Methylin ER, Ritalin SR)</td>
<td>Mydayis <sup>QL</sup></td>
</tr>
<tr>
<td>Methylphenidate Sol <sup>AR QL</sup></td>
<td>Vyvanse Chewable Tab</td>
</tr>
<tr>
<td>Methylphenidate Tab <sup>AR QL</sup></td>
<td>Xelstrym <sup>AR</sup></td>
</tr>
<tr>
<td>Procentra <sup>AR</sup></td>
<td>Zenzedi <sup>AR QL</sup></td>
</tr>
<tr>
<td>Qelbree <sup>ST</sup></td>
<td></td>
</tr>
<tr>
<td>Quillichew ER <sup>AR</sup></td>
<td></td>
</tr>
<tr>
<td>Quillivant XR <sup>AR</sup></td>
<td></td>
</tr>
<tr>
<td>Ritalin LA <sup>AR QL</sup></td>
<td></td>
</tr>
<tr>
<td>Vyvanse Cap <sup>QL</sup></td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=35" rel="noopener">Link to Criteria: Central Nervous System (CNS) Agents: Attention Deficit Hyperactivity Disorder Agents</a></p>
<p><strong>Atypical Antipsychotics</strong>*</p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Abilify Maintena <sup>QL</sup></td>
<td>Abilify Mycite</td>
</tr>
<tr>
<td>Aripiprazole <sup>QL</sup></td>
<td>Aripiprazole Sol</td>
</tr>
<tr>
<td>Aristada <sup>QL</sup></td>
<td>Asenapine</td>
</tr>
<tr>
<td>Aristada Initio</td>
<td>Caplyta</td>
</tr>
<tr>
<td>Clozapine</td>
<td>Clozapine ODT Rapdis</td>
</tr>
<tr>
<td>Fanapt <sup>ST</sup></td>
<td>Fluoxetine/Olanzapine</td>
</tr>
<tr>
<td>Geodon <sup>QL</sup></td>
<td>Lybalvi</td>
</tr>
<tr>
<td>Invega Hafyera ER <sup>PA</sup></td>
<td>Nuplazid</td>
</tr>
<tr>
<td>Invega Sustenna <sup>QL</sup></td>
<td>Olanzapine ODT</td>
</tr>
<tr>
<td>Invega Trinza <sup>QL</sup></td>
<td>Rexulti</td>
</tr>
<tr>
<td>Lurasidone <sup>QL</sup></td>
<td>Secuado</td>
</tr>
<tr>
<td>Olanzapine <sup>QL</sup></td>
<td>Versacloz</td>
</tr>
<tr>
<td>Paliperdone Tab</td>
<td>Vraylar</td>
</tr>
<tr>
<td>Perseris</td>
<td>Zyprexa Relprevv <sup>QL</sup></td>
</tr>
<tr>
<td>Quetiapine IR, ER <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Risperdal Consta <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Risperidone <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Saphris <sup>BvG ST</sup></td>
<td></td>
</tr>
<tr>
<td>Ziprasidone <sup>QL</sup></td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=36" rel="noopener">Link to Criteria: Central Nervous System (CNS) Agents: Atypical Antipsychotics</a></p>
<p><strong>Fibromyalgia Agents</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Pregabalin <sup>QL</sup></td>
<td>Savella</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=38" rel="noopener">Link to Criteria: Central Nervous System (CNS) Agents: Fibromyalgia Agents</a></p>
<p><strong>Medication Assisted Treatment of Opioid Addiction</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Buprenorphine/Naloxone</td>
<td>Buprenorphine</td>
</tr>
<tr>
<td>Clonidine</td>
<td>Lucemyra <sup>QL</sup></td>
</tr>
<tr>
<td>Sublocade <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Suboxone</td>
<td></td>
</tr>
<tr>
<td>Vivitrol</td>
<td></td>
</tr>
<tr>
<td>Zubsolv</td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=39" rel="noopener">Link to Criteria: Central Nervous System (CNS) Agents: Medication Assisted Treatment of Opioid Addiction</a></p>
<p><strong>Movement Disorders</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Austedo <sup>PA ST</sup></td>
<td></td>
</tr>
<tr>
<td>Ingrezza <sup>PA</sup></td>
<td></td>
</tr>
<tr>
<td>Tetrabenazine <sup>PA</sup></td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=41" rel="noopener">Link to Criteria: Central Nervous System (CNS) Agents: Movement Disorders</a></p>
<p><strong>Multiple Sclerosis</strong>*</p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Aubagio <sup>BvG</sup></td>
<td>Bafiertam</td>
</tr>
<tr>
<td>Avonex</td>
<td>Extavia</td>
</tr>
<tr>
<td>Betaseron</td>
<td>Glatiramer</td>
</tr>
<tr>
<td>Copaxone <sup>BvG</sup></td>
<td>Glatopa</td>
</tr>
<tr>
<td>Dalfampridine</td>
<td>Kesimpta</td>
</tr>
<tr>
<td>Dimethyl Fumarate</td>
<td>Mavenclad</td>
</tr>
<tr>
<td>Gilenya</td>
<td>Mayzent</td>
</tr>
<tr>
<td>Fingolimod</td>
<td>Plegridy</td>
</tr>
<tr>
<td>Rebif</td>
<td>Ponvory</td>
</tr>
<tr>
<td></td>
<td>Tascenso ODT</td>
</tr>
<tr>
<td></td>
<td>Teriflunomide</td>
</tr>
<tr>
<td></td>
<td>Vumerity</td>
</tr>
<tr>
<td></td>
<td>Zeposia</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=42" rel="noopener">Link to Criteria: Central Nervous System (CNS) Agents: Multiple Sclerosis</a></p>
<p><strong>Narcolepsy</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Amphetamine/Dextroamphetamine IR/ER <sup>AR</sup></td>
<td>Sunosi</td>
</tr>
<tr>
<td>Armodafinil</td>
<td>Wakix</td>
</tr>
<tr>
<td>Dextroamphetamine ER <sup>AR</sup></td>
<td>Xyrem <sup>BvG</sup></td>
</tr>
<tr>
<td>Methylphenidate ER <sup>AR</sup></td>
<td>Xywav</td>
</tr>
<tr>
<td>Methylphenidate Tab <sup>AR</sup></td>
<td></td>
</tr>
<tr>
<td>Modafinil</td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=43" rel="noopener">Link to Criteria: Central Nervous System (CNS) Agents: Narcolepsy</a></p>
<p><strong>Neuropathic Pain</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Amitriptyline</td>
<td>Gralise</td>
</tr>
<tr>
<td>Carbamazepine</td>
<td>Horizant</td>
</tr>
<tr>
<td>Desipramine</td>
<td>Pregabalin ER</td>
</tr>
<tr>
<td>Doxepin 10, 25, 50, 75, 100, 150mg</td>
<td>Ztlido</td>
</tr>
<tr>
<td>Doxepin Sol</td>
<td></td>
</tr>
<tr>
<td>Duloxetine <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Gabapentin <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Imipramine</td>
<td></td>
</tr>
<tr>
<td>Lidocaine Patch</td>
<td></td>
</tr>
<tr>
<td>Nortriptyline</td>
<td></td>
</tr>
<tr>
<td>Oxcarbazepine</td>
<td></td>
</tr>
<tr>
<td>Pregabalin <sup>QL</sup></td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=44" rel="noopener">Link to Criteria: Central Nervous System (CNS) Agents: Neuropathic Pain</a></p>
<p><strong>Parkinson's Agents</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Amantadine</td>
<td>Apokyn</td>
</tr>
<tr>
<td>Carbidopa</td>
<td>Carbidopa/Levodopa Dispersible Tab</td>
</tr>
<tr>
<td>Carbidopa/Levodopa</td>
<td>Carbidopa/Levodopa/Entacapone</td>
</tr>
<tr>
<td>Entacapone</td>
<td>Gocovri</td>
</tr>
<tr>
<td>Pramipexole</td>
<td>Inbrija</td>
</tr>
<tr>
<td>Ropinirole</td>
<td>Kynmobi</td>
</tr>
<tr>
<td>Selegiline</td>
<td>Neupro</td>
</tr>
<tr>
<td></td>
<td>Nourianz</td>
</tr>
<tr>
<td></td>
<td>Ongentys</td>
</tr>
<tr>
<td></td>
<td>Osmolex ER</td>
</tr>
<tr>
<td></td>
<td>Pramipexole ER</td>
</tr>
<tr>
<td></td>
<td>Rasagiline</td>
</tr>
<tr>
<td></td>
<td>Ropinirole ER</td>
</tr>
<tr>
<td></td>
<td>Rytary</td>
</tr>
<tr>
<td></td>
<td>Tolcapone</td>
</tr>
<tr>
<td></td>
<td>Xadago</td>
</tr>
<tr>
<td></td>
<td>Zelapar</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=45" rel="noopener">Link to Criteria: Central Nervous System (CNS) Agents: Parkinson's Agents</a></p>
<p><strong>Restless Legs Syndrome</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Pramipexole</td>
<td>Horizant</td>
</tr>
<tr>
<td>Ropinirole</td>
<td>Neupro</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=46" rel="noopener">Link to Criteria: Central Nervous System (CNS) Agents: Restless Legs Syndrome</a></p>
<p><strong>Sedative-Hypnotics, Non-Barbiturate</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Estazolam <sup>QL</sup></td>
<td>Belsomra</td>
</tr>
<tr>
<td>Temazepam 15, 30mg <sup>QL</sup></td>
<td>Dayvigo</td>
</tr>
<tr>
<td>Zaleplon <sup>QL</sup></td>
<td>Doxepin 3, 6mg</td>
</tr>
<tr>
<td>Zolpidem <sup>QL</sup></td>
<td>Eszopiclone <sup>QL</sup></td>
</tr>
<tr>
<td></td>
<td>Intermezzo</td>
</tr>
<tr>
<td></td>
<td>Quviviq</td>
</tr>
<tr>
<td></td>
<td>Ramelteon</td>
</tr>
<tr>
<td></td>
<td>Temazepam 7.5, 22mg <sup>QL</sup></td>
</tr>
<tr>
<td></td>
<td>Zolpidem ER, SL</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=47" rel="noopener">Link to Criteria: Central Nervous System (CNS) Agents: Sedative-Hypnotics, Non-Barbiturate</a></p>
<p><strong>Skeletal Muscle Relaxants, Non-Benzodiazepine</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Baclofen Tab</td>
<td>Baclofen Solution</td>
</tr>
<tr>
<td>Chlorzoxazone 250, 500mg <sup>QL</sup></td>
<td>Carisoprodol</td>
</tr>
<tr>
<td>Cyclobenzaprine 5, 10mg <sup>QL</sup></td>
<td>Chlorzoxazone 375, 750mg <sup>QL</sup></td>
</tr>
<tr>
<td>Dantrolene</td>
<td>Cyclobenzaprine 7.5mg <sup>QL</sup></td>
</tr>
<tr>
<td>Methocarbamol <sup>QL</sup></td>
<td>Cyclobenzaprine ER <sup>QL</sup></td>
</tr>
<tr>
<td>Tizanidine Tab <sup>QL</sup></td>
<td>Fleqsuvy <sup>BvG</sup></td>
</tr>
<tr>
<td></td>
<td>Lyvispah</td>
</tr>
<tr>
<td></td>
<td>Metaxalone</td>
</tr>
<tr>
<td></td>
<td>Orphenadrine</td>
</tr>
<tr>
<td></td>
<td>Tizanidine Cap</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=48" rel="noopener">Link to Criteria: Central Nervous System (CNS) Agents: Skeletal Muscle Relaxants, Non-Benzodiazepine</a></p>
<p><strong>Smoking Deterrents</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nicotine <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Bupropion <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Chantix <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Varenicline <sup>QL</sup></td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=49" rel="noopener">Link to Criteria: Central Nervous System (CNS) Agents: Smoking Deterrents</a></p>
<h2 id="dermatological_agents">Dermatological Agents<a class="headerlink" href="#dermatological_agents" title="Permanent link">&para;</a></h2>
<p><strong>Oral Acne Products</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Accutane <sup>PA</sup></td>
<td>Absorica</td>
</tr>
<tr>
<td>Amnesteem <sup>PA</sup></td>
<td>Absorica LD</td>
</tr>
<tr>
<td>Claravis <sup>PA</sup></td>
<td></td>
</tr>
<tr>
<td>Isotretinoin <sup>PA</sup></td>
<td></td>
</tr>
<tr>
<td>Myorisan <sup>PA</sup></td>
<td></td>
</tr>
<tr>
<td>Zenatane <sup>PA</sup></td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=50" rel="noopener">Link to Criteria: Dermatological: Oral Acne Products</a></p>
<p><strong>Topical Acne Products</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Adapalene Gel 0.1% <sup>AR</sup></td>
<td>Adapalene Cream, Sol 0.1% <sup>AR</sup></td>
</tr>
<tr>
<td>Benzoyl Peroxide</td>
<td>Adapalene Gel 0.3%  <sup>AR</sup></td>
</tr>
<tr>
<td>Clindamycin Gel, Lot, Sol</td>
<td>Adapalene/Benzoyl Peroxide <sup>AR</sup></td>
</tr>
<tr>
<td>Clindamycin/Benzoyl Peroxide</td>
<td>Aklief <sup>AR</sup></td>
</tr>
<tr>
<td>Erythromycin</td>
<td>Altreno <sup>AR</sup></td>
</tr>
<tr>
<td>Erythromycin/Benzoyl Peroxide</td>
<td>Amzeeq</td>
</tr>
<tr>
<td>Neuac</td>
<td>Arazlo <sup>AR</sup></td>
</tr>
<tr>
<td>Sodium Sulfacetamide</td>
<td>Azelaic Acid Gel</td>
</tr>
<tr>
<td>Sodium Sulfacetamide/Sulfur Cream</td>
<td>Benzoyl Peroxide Foam</td>
</tr>
<tr>
<td>Sodium Sulfacetamide/Sulfur Wash Susp</td>
<td>Clindacin Kit</td>
</tr>
<tr>
<td>Tretinoin <sup>AR</sup></td>
<td>Clindamycin Foam, Swabs</td>
</tr>
<tr>
<td></td>
<td>Clindamycin/Tretinoin <sup>AR</sup></td>
</tr>
<tr>
<td></td>
<td>Dapsone Gel</td>
</tr>
<tr>
<td></td>
<td>Epsolay</td>
</tr>
<tr>
<td></td>
<td>Finacea Foam</td>
</tr>
<tr>
<td></td>
<td>Onexton Gel</td>
</tr>
<tr>
<td></td>
<td>Ovace Plus</td>
</tr>
<tr>
<td></td>
<td>Plixda <sup>AR</sup></td>
</tr>
<tr>
<td></td>
<td>Sodium Sulfacetamide/Sulfur Gel</td>
</tr>
<tr>
<td></td>
<td>Sodium Sulfacetamide Pads</td>
</tr>
<tr>
<td></td>
<td>Tazarotene Cream, Foam, Gel 0.1% <sup>AR</sup></td>
</tr>
<tr>
<td></td>
<td>Twyneo <sup>AR</sup></td>
</tr>
<tr>
<td></td>
<td>Winlevi</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=51" rel="noopener">Link to Criteria: Dermatological: Topical Acne Products</a></p>
<h2 id="endocrine_agents">Endocrine Agents<a class="headerlink" href="#endocrine_agents" title="Permanent link">&para;</a></h2>
<p><strong>Androgens</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Androderm <sup>AR PA</sup></td>
<td>Jatenzo <sup>AR</sup></td>
</tr>
<tr>
<td>Testosterone Gel 1% <sup>AR PA</sup></td>
<td>Methyltestosterone <sup>AR</sup></td>
</tr>
<tr>
<td>Testosterone Gel 1% Pump <sup>AR PA</sup></td>
<td>Natesto <sup>AR</sup></td>
</tr>
<tr>
<td></td>
<td>Testopel <sup>AR</sup></td>
</tr>
<tr>
<td></td>
<td>Testosterone Cypionate <sup>AR</sup></td>
</tr>
<tr>
<td></td>
<td>Testosterone Gel 1.62%, 2% <sup>AR</sup></td>
</tr>
<tr>
<td></td>
<td>Testosterone Sol 30mg/ACT <sup>AR</sup></td>
</tr>
<tr>
<td></td>
<td>Tlando <sup>AR</sup></td>
</tr>
<tr>
<td></td>
<td>Xyosted <sup>AR</sup></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=52" rel="noopener">Link to Criteria: Endocrine Agents: Androgens</a></p>
<p><strong>Diabetes - Hypoglycemia Treatments</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Baqsimi <sup>QL</sup></td>
<td>Glucagon Emerg Kit [Labeler 00548 &amp; 63323] <sup>QL</sup></td>
</tr>
<tr>
<td>Glucagen Hypokit <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Glucagon Emerg Kit [Labeler 00002] <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Gvoke <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Zegalogue <sup>QL</sup></td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=53" rel="noopener">Link to Criteria: Endocrine Agents: Diabetes - Hypoglycemia Treatments</a></p>
<p><strong>Diabetes - Insulin</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Apidra</td>
<td>Admelog <sup>QL</sup></td>
</tr>
<tr>
<td>Humalog 50-50</td>
<td>Afrezza</td>
</tr>
<tr>
<td>Humalog 75-25</td>
<td>Basaglar <sup>QL</sup></td>
</tr>
<tr>
<td>Humalog U-100 Kwikpen Vial <sup>QL</sup></td>
<td>Fiasp <sup>QL</sup></td>
</tr>
<tr>
<td>Humulin 70-30</td>
<td>Humalog U-100 Tempo Pen</td>
</tr>
<tr>
<td>Humulin R U-500 <sup>QL</sup></td>
<td>Humalog U-200 <sup>QL</sup></td>
</tr>
<tr>
<td>Insulin Aspart <sup>QL</sup></td>
<td>Humulin N U-100</td>
</tr>
<tr>
<td>Insulin Aspart Protamine/Insulin Aspart</td>
<td>Humulin R U-100</td>
</tr>
<tr>
<td>Insulin Lispro <sup>QL</sup></td>
<td>Insulin Degludec</td>
</tr>
<tr>
<td>Lantus <sup>BvG QL</sup></td>
<td>Lyumjev</td>
</tr>
<tr>
<td>Levemir</td>
<td>Novolin 70-30</td>
</tr>
<tr>
<td>Novolog 70-30</td>
<td>Novolin N U-100</td>
</tr>
<tr>
<td>Novolog U-100 <sup>QL</sup></td>
<td>Novolin R U-100</td>
</tr>
<tr>
<td>Toujeo</td>
<td>Semglee <sup>BvG QL</sup></td>
</tr>
<tr>
<td>Tresiba <sup>BvG ST</sup></td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=54" rel="noopener">Link to Criteria: Endocrine Agents: Diabetes - Insulin</a></p>
<p><strong>Diabetes - Non-Insulin</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Acarbose <sup>QL</sup></td>
<td>Adlyxin</td>
</tr>
<tr>
<td>Actoplus Met XR</td>
<td>Alogliptin</td>
</tr>
<tr>
<td>Byetta</td>
<td>Alogliptin/Metformin</td>
</tr>
<tr>
<td>Farxiga</td>
<td>Bydureon Bcise</td>
</tr>
<tr>
<td>Glimepiride <sup>QL</sup></td>
<td>Glimepiride/Pioglitazone</td>
</tr>
<tr>
<td>Glipizide <sup>QL</sup></td>
<td>Glucophage</td>
</tr>
<tr>
<td>Glipizide/Metformin <sup>QL</sup></td>
<td>Glyxambi</td>
</tr>
<tr>
<td>Glyburide <sup>QL</sup></td>
<td>Invokamet XR</td>
</tr>
<tr>
<td>Glyburide/Metformin <sup>QL</sup></td>
<td>Jentadueto XR</td>
</tr>
<tr>
<td>Invokamet</td>
<td>Kombiglyze XR</td>
</tr>
<tr>
<td>Invokana</td>
<td>Metformin ER <sup>QL</sup> (Generic of Fortamet, Glumetza)</td>
</tr>
<tr>
<td>Janumet</td>
<td>Metformin Sol</td>
</tr>
<tr>
<td>Janumet XR</td>
<td>Mounjaro</td>
</tr>
<tr>
<td>Januvia</td>
<td>Onglyza</td>
</tr>
<tr>
<td>Jardiance</td>
<td>Ozempic</td>
</tr>
<tr>
<td>Jentadueto</td>
<td>Pioglitazone/Alogliptin</td>
</tr>
<tr>
<td>Metformin IR, ER <sup>QL</sup> (Generic of Glucophage XR)</td>
<td>Qtern</td>
</tr>
<tr>
<td></td>
<td>Rybelsus</td>
</tr>
<tr>
<td>Miglitol</td>
<td>Segluromet</td>
</tr>
<tr>
<td>Nateglinide <sup>QL</sup></td>
<td>Soliqua</td>
</tr>
<tr>
<td>Pioglitazone <sup>QL</sup></td>
<td>Steglatro</td>
</tr>
<tr>
<td>Pioglitazone/Metformin <sup>QL</sup></td>
<td>Steglujan</td>
</tr>
<tr>
<td>Repaglinide</td>
<td>Symlinpen</td>
</tr>
<tr>
<td>Repaglinide/Metformin</td>
<td>Synjardy XR</td>
</tr>
<tr>
<td>Synjardy</td>
<td>Trijardy XR</td>
</tr>
<tr>
<td>Tradjenta</td>
<td>Xigduo XR</td>
</tr>
<tr>
<td>Trulicity <sup>QL</sup></td>
<td>Xultophy</td>
</tr>
<tr>
<td>Victoza <sup>QL</sup></td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=56" rel="noopener">Link to Criteria: Endocrine Agents: Diabetes - Non-Insulin</a></p>
<p><strong>Endometriosis</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Danazol <sup>ST</sup></td>
<td>Synarel</td>
</tr>
<tr>
<td>Depo-Subq Provera 104 <sup>ST</sup></td>
<td></td>
</tr>
<tr>
<td>Lupaneta Pack <sup>ST</sup></td>
<td></td>
</tr>
<tr>
<td>Lupron Depot <sup>QL ST</sup> 3.75, 11.25mg</td>
<td></td>
</tr>
<tr>
<td>Myfembree <sup>QL ST</sup></td>
<td></td>
</tr>
<tr>
<td>Orilissa <sup>ST</sup></td>
<td></td>
</tr>
<tr>
<td>Zoladex <sup>ST</sup></td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=57" rel="noopener">Link to Criteria: Endocrine Agents: Endometriosis</a></p>
<p><strong>Estrogenic Agents</strong></p>
<table>
<thead>
<tr>
<th>Prefered</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Climara Pro <sup>QL</sup></td>
<td>Angeliq</td>
</tr>
<tr>
<td>Combipatch <sup>QL</sup></td>
<td>Climara <sup>QL</sup></td>
</tr>
<tr>
<td>Dotti <sup>QL</sup></td>
<td>Divigel <sup>BvG</sup></td>
</tr>
<tr>
<td>Estradiol Cream, Tab</td>
<td>Duavee</td>
</tr>
<tr>
<td>Estradiol Patch <sup>QL</sup></td>
<td>Elestrin <sup>BvG</sup></td>
</tr>
<tr>
<td>Lyllana <sup>QL</sup></td>
<td>Estradiol 10 MCG Vag Tab</td>
</tr>
<tr>
<td>Estring <sup>QL</sup></td>
<td>Estradiol/Norethindrone Acetate</td>
</tr>
<tr>
<td>Ethinyl Estradiol/Norethindrone Acetate</td>
<td>Estrogel <sup>BvG</sup></td>
</tr>
<tr>
<td>Menest</td>
<td>Evamist</td>
</tr>
<tr>
<td>Premarin</td>
<td>Femring</td>
</tr>
<tr>
<td>Premphase</td>
<td>Menostar <sup>QL</sup></td>
</tr>
<tr>
<td>Prempro</td>
<td>Minivelle <sup>QL</sup></td>
</tr>
<tr>
<td></td>
<td>Prefest</td>
</tr>
<tr>
<td></td>
<td>Vivelle-Dot <sup>QL</sup></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=58" rel="noopener">Link to Criteria: Endocrine Agents: Estrogenic Agents</a></p>
<p><strong>Growth Hormone</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Genotropin <sup>PA</sup></td>
<td>Humatrope</td>
</tr>
<tr>
<td>Norditropin <sup>PA</sup></td>
<td>Nutropin</td>
</tr>
<tr>
<td></td>
<td>Omnitrope</td>
</tr>
<tr>
<td></td>
<td>Saizen</td>
</tr>
<tr>
<td></td>
<td>Serostim</td>
</tr>
<tr>
<td></td>
<td>Skytrofa</td>
</tr>
<tr>
<td></td>
<td>Zomacton</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=59" rel="noopener">Link to Criteria: Endocrine Agents: Growth Hormone</a></p>
<p><strong>Osteoporosis - Bone Ossification Enhancers</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Alendronate Tab</td>
<td>Alendronate Susp</td>
</tr>
<tr>
<td>Calcitonin-Salmon</td>
<td>Fosamax Plus D</td>
</tr>
<tr>
<td>Forteo <sup>PA QL</sup></td>
<td>Risedronate</td>
</tr>
<tr>
<td>Ibandronate</td>
<td>Tymlos <sup>QL</sup></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=61" rel="noopener">Link to Criteria: Endocrine Agents: Osteoporosis - Bone Ossification Enhancers</a></p>
<p><strong>Progestin Agents</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Hydroxyprogesterone Caproate <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Makena <sup>QL</sup></td>
<td></td>
</tr>
<tr>
<td>Medroxyprogesterone Acetate Tab</td>
<td></td>
</tr>
<tr>
<td>Megestrol</td>
<td></td>
</tr>
<tr>
<td>Norethindrone Acetate</td>
<td></td>
</tr>
<tr>
<td>Progesterone</td>
<td></td>
</tr>
<tr>
<td>Progesterone In Oil</td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=62" rel="noopener">Link to Criteria: Endocrine Agents: Progestin Agents</a></p>
<p><strong>Uterine Fibroids</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lupron Depot <sup>PA</sup> 3.75, 11.25mg</td>
<td></td>
</tr>
<tr>
<td>Myfembree <sup>PA QL</sup></td>
<td></td>
</tr>
<tr>
<td>Oriahnn <sup>PA QL</sup></td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=63" rel="noopener">Link to Criteria: Endocrine Agents: Uterine Fibroids</a></p>
<h2 id="gastrointestinal_agents">Gastrointestinal Agents<a class="headerlink" href="#gastrointestinal_agents" title="Permanent link">&para;</a></h2>
<p><strong>Anti-Emetics</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Aprepitant 40, 125mg</td>
<td>Aprepitant 80mg</td>
</tr>
<tr>
<td>Diclegis <sup>BvG</sup></td>
<td>Aprepitant TriPac</td>
</tr>
<tr>
<td>Dimenhydrinate</td>
<td>Bonjesta</td>
</tr>
<tr>
<td>Diphenhydramine</td>
<td>Doxylamine/Pyridoxine</td>
</tr>
<tr>
<td>Emend 125mg Susp</td>
<td>Metoclopramide ODT</td>
</tr>
<tr>
<td>Emend 80mg <sup>BvG</sup></td>
<td>Sancuso</td>
</tr>
<tr>
<td>Emend TriPac <sup>BvG</sup></td>
<td>Zuplenz</td>
</tr>
<tr>
<td>Meclizine</td>
<td></td>
</tr>
<tr>
<td>Metoclopramide</td>
<td></td>
</tr>
<tr>
<td>Ondansetron</td>
<td></td>
</tr>
<tr>
<td>Phosphorated Carbohydrate</td>
<td></td>
</tr>
<tr>
<td>Prochlorperazine</td>
<td></td>
</tr>
<tr>
<td>Promethazine</td>
<td></td>
</tr>
<tr>
<td>Scopolamine</td>
<td></td>
</tr>
<tr>
<td>Trimethobenzamide</td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=64" rel="noopener">Link to Criteria: Gastrointestinal Agents: Anti-Emetics</a></p>
<p><strong>Crohn's Disease</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Azathioprine</td>
<td>Ortikos ER</td>
</tr>
<tr>
<td>Budesonide ER Cap</td>
<td></td>
</tr>
<tr>
<td>Mercaptopurine</td>
<td></td>
</tr>
<tr>
<td>Methotrexate</td>
<td></td>
</tr>
<tr>
<td>Sulfasalazine</td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=65" rel="noopener">Link to Criteria: Gastrointestinal Agents: Crohn's Disease</a></p>
<p><strong>Hepatic Encephalopathy</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lactulose</td>
<td></td>
</tr>
<tr>
<td>Xifaxan <sup>ST</sup></td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=66" rel="noopener">Link to Criteria: Gastrointestinal Agents: Hepatic Encephalopathy</a></p>
<p><strong>Irritable Bowel Syndrome (IBS) with Diarrhea</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Diphenoxylate/Atropine</td>
<td>Alosetron</td>
</tr>
<tr>
<td>Loperamide <sup>QL</sup></td>
<td>Viberzi</td>
</tr>
<tr>
<td>Xifaxan <sup>ST</sup></td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=67" rel="noopener">Link to Criteria: Gastrointestinal Agents: Irritable Bowel Sydrome (IBS) with Diarrhea</a></p>
<p><strong>Pancreatic Enzymes</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Creon</td>
<td>Pancreaze</td>
</tr>
<tr>
<td>Zenpep</td>
<td>Pertzye</td>
</tr>
<tr>
<td></td>
<td>Viokace</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=68" rel="noopener">Link to Criteria: Gastrointestinal Agents: Pancreatic Enzymes</a></p>
<p><strong>Proton Pump Inhibitors</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lansoprazole Cap</td>
<td>Aciphex</td>
</tr>
<tr>
<td>Nexium Granules <sup>BvG</sup></td>
<td>Dexilant <sup>BvG</sup></td>
</tr>
<tr>
<td>Omeprazole Cap <sup>AR</sup></td>
<td>Esomeprazole</td>
</tr>
<tr>
<td>Pantoprazole Tab <sup>AR</sup></td>
<td>Esomeprazole Granules</td>
</tr>
<tr>
<td>Protonix Pak <sup>AR BvG</sup></td>
<td>Lansoprazole ODT</td>
</tr>
<tr>
<td></td>
<td>Omeprazole Tab <sup>AR</sup></td>
</tr>
<tr>
<td></td>
<td>Omeprazole/Sodium Bicarbonate</td>
</tr>
<tr>
<td></td>
<td>Pantoprazole Packet</td>
</tr>
<tr>
<td></td>
<td>Prilosec Susp</td>
</tr>
<tr>
<td></td>
<td>Rabeprazole</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=69" rel="noopener">Link to Criteria: Gastrointestinal Agents: Proton Pump Inhibitors</a></p>
<p><strong>Ulcerative Colitis</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Balsalazide Disodium</td>
<td>Dipentum</td>
</tr>
<tr>
<td>Budesonide ER Tab <sup>QL</sup></td>
<td>Mesalamine Supp</td>
</tr>
<tr>
<td>Mesalamine DR Cap, Tab</td>
<td>Uceris Foam <sup>QL BvG</sup></td>
</tr>
<tr>
<td>Mesalamine Enema</td>
<td>Zeposia</td>
</tr>
<tr>
<td>Mesalamine ER</td>
<td></td>
</tr>
<tr>
<td>Pentasa <sup>BvG</sup></td>
<td></td>
</tr>
<tr>
<td>Sulfasalazine</td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=70" rel="noopener">Link to Criteria: Gastrointestinal Agents: Ulcerative Colitis</a></p>
<p><strong>Unspecified GI</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Amitiza <sup>ST</sup></td>
<td>Aemcolo</td>
</tr>
<tr>
<td>Bisacodyl</td>
<td>Gattex</td>
</tr>
<tr>
<td>Casanthranol/Docusate Sodium</td>
<td>Ibsrela</td>
</tr>
<tr>
<td>Dicyclomine</td>
<td>Linzess 72mcg</td>
</tr>
<tr>
<td>Diphenoxylate/Atropine</td>
<td>Motegrity</td>
</tr>
<tr>
<td>Lactulose</td>
<td>Mytesi</td>
</tr>
<tr>
<td>Linzess <sup>ST</sup> 145, 290mcg</td>
<td>Relistor</td>
</tr>
<tr>
<td>Loperamide</td>
<td>Symproic</td>
</tr>
<tr>
<td>Lubiprostone <sup>ST</sup></td>
<td>Zorbtive</td>
</tr>
<tr>
<td>Movantik <sup>ST</sup></td>
<td></td>
</tr>
<tr>
<td>Polyethylene Glycol</td>
<td></td>
</tr>
<tr>
<td>Psyllium Fiber</td>
<td></td>
</tr>
<tr>
<td>Senna</td>
<td></td>
</tr>
<tr>
<td>Trulance <sup>ST</sup></td>
<td></td>
</tr>
<tr>
<td>Xifaxan <sup>ST</sup></td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=71" rel="noopener">Link to Criteria: Gastrointestinal Agents: Unspecified GI</a></p>
<h2 id="genitourinary_agents">Genitourinary Agents<a class="headerlink" href="#genitourinary_agents" title="Permanent link">&para;</a></h2>
<p><strong>Benign Prostatic Hyperplasia</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Alfuzosin</td>
<td>Cardura XL</td>
</tr>
<tr>
<td>Doxazosin</td>
<td>Dutasteride/Tamsulosin</td>
</tr>
<tr>
<td>Dutasteride</td>
<td>Entadfi</td>
</tr>
<tr>
<td>Finasteride</td>
<td>Silodosin</td>
</tr>
<tr>
<td>Prazosin</td>
<td></td>
</tr>
<tr>
<td>Tadalafil <sup>PA</sup> 2.5, 5mg</td>
<td></td>
</tr>
<tr>
<td>Tamsulosin</td>
<td></td>
</tr>
<tr>
<td>Terazosin</td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=72" rel="noopener">Link to Criteria: Genitourinary Agents: Benign Prostatic Hyperplasia</a></p>
<p><strong>Electrolyte Depleter Agents</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Calcium Acetate, Carbonate</td>
<td>Auryxia</td>
</tr>
<tr>
<td>Phoslyra</td>
<td>Lanthanum Carbonate</td>
</tr>
<tr>
<td>Sevelamer</td>
<td>Velphoro</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=73" rel="noopener">Link to Criteria: Genitourinary Agents: Electrolyte Depleter Agents</a></p>
<p><strong>Urinary Antispasmodics</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Gelnique</td>
<td>Darifenacin <sup>QL</sup></td>
</tr>
<tr>
<td>Myrbetriq Tab</td>
<td>Fesoterodine</td>
</tr>
<tr>
<td>Oxybutynin <sup>QL</sup></td>
<td>Gemtesa</td>
</tr>
<tr>
<td>Oxytrol</td>
<td>Myrbetriq Granules <sup>AR</sup></td>
</tr>
<tr>
<td>Solifenacin <sup>QL</sup></td>
<td>Tolterodine</td>
</tr>
<tr>
<td>Toviaz <sup>BvG</sup></td>
<td>Trospium <sup>QL</sup></td>
</tr>
<tr>
<td></td>
<td>Vesicare LS <sup>AR</sup></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=74" rel="noopener">Link to Criteria: Genitourinary Agents: Urinary Antispasmodics</a></p>
<h2 id="immunomodulator_agents">Immunomodulator Agents<a class="headerlink" href="#immunomodulator_agents" title="Permanent link">&para;</a></h2>
<p><strong>Systemic Inflammatory Disease</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Adbry <sup>PA</sup></td>
<td>Actemra</td>
</tr>
<tr>
<td>Enbrel <sup>PA</sup></td>
<td>Cibinqo</td>
</tr>
<tr>
<td>Dupixent <sup>PA</sup></td>
<td>Cimzia</td>
</tr>
<tr>
<td>Humira <sup>PA</sup></td>
<td>Cosentyx</td>
</tr>
<tr>
<td>Kineret <sup>PA</sup></td>
<td>Ilumya</td>
</tr>
<tr>
<td>Otezla <sup>PA</sup></td>
<td>Kevzara</td>
</tr>
<tr>
<td>Taltz <sup>PA ST</sup></td>
<td>Olumiant</td>
</tr>
<tr>
<td>Xeljanz IR <sup>PA</sup></td>
<td>Orencia</td>
</tr>
<tr>
<td></td>
<td>Rinvoq</td>
</tr>
<tr>
<td></td>
<td>Siliq</td>
</tr>
<tr>
<td></td>
<td>Simponi</td>
</tr>
<tr>
<td></td>
<td>Skyrizi</td>
</tr>
<tr>
<td></td>
<td>Sotyktu</td>
</tr>
<tr>
<td></td>
<td>Stelara</td>
</tr>
<tr>
<td></td>
<td>Tremfya</td>
</tr>
<tr>
<td></td>
<td>Xeljanz Sol, XR</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=75" rel="noopener">Link to Criteria: Immunomodulator Agents for Systemic Inflammatory Disease</a></p>
<h2 id="infectious_disease_agents">Infectious Disease Agents<a class="headerlink" href="#infectious_disease_agents" title="Permanent link">&para;</a></h2>
<p><strong>Antibiotics - Cephalosporins</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Cefadroxil</td>
<td>Cephalexin 750mg</td>
</tr>
<tr>
<td>Cephalexin 250, 500mg</td>
<td>Cefpodoxime</td>
</tr>
<tr>
<td>Cefaclor IR, ER</td>
<td>Cefixime Cap</td>
</tr>
<tr>
<td>Cefaclor Susp <sup>AR</sup></td>
<td>Cefixime Susp <sup>AR</sup></td>
</tr>
<tr>
<td>Cefprozil</td>
<td>Suprax Chewable Tab <sup>AR</sup></td>
</tr>
<tr>
<td>Cefprozil Susp <sup>AR</sup></td>
<td></td>
</tr>
<tr>
<td>Cefuroxime</td>
<td></td>
</tr>
<tr>
<td>Cefdinir</td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=77" rel="noopener">Link to Criteria: Infectious Disease Agents: Antibiotics - Cephalosporins</a></p>
<p><strong>Antibiotics - Inhaled</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Tobramycin <sup>PA QL</sup></td>
<td>Arikayce</td>
</tr>
<tr>
<td></td>
<td>Bethkis <sup>QL</sup></td>
</tr>
<tr>
<td></td>
<td>Cayston</td>
</tr>
<tr>
<td></td>
<td>Kitabis Pak <sup>QL</sup></td>
</tr>
<tr>
<td></td>
<td>Tobi Podhaler <sup>QL</sup></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=78" rel="noopener">Link to Criteria: Infectious Disease Agents: Antibiotics - Inhaled</a></p>
<p><strong>Antibiotics - Macrolides</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Azithromycin</td>
<td>Eryped</td>
</tr>
<tr>
<td>Clarithromycin</td>
<td>Erythrocin Stearate</td>
</tr>
<tr>
<td></td>
<td>Erythromycin</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=79" rel="noopener">Link to Criteria: Infectious Disease Agents: Antibiotics - Macrolides</a></p>
<p><strong>Antibiotics - Quinolones</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ciprofloxacin</td>
<td>Baxdela</td>
</tr>
<tr>
<td>Ciprofloxacin Susp <sup>AR</sup></td>
<td>Ciprofloxacin ER</td>
</tr>
<tr>
<td>Levofloxacin</td>
<td>Moxifloxacin</td>
</tr>
<tr>
<td></td>
<td>Ofloxacin</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=80" rel="noopener">Link to Criteria: Infectious Disease Agents: Antibiotics - Quinolones</a></p>
<p><strong>Antibiotics - Tetracyclines</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Doxycycline 50, 100mg</td>
<td>Demeclocycline</td>
</tr>
<tr>
<td>Doxycycline Syr <sup>AR</sup></td>
<td>Doxycycline 20, 40, 75, 150mg</td>
</tr>
<tr>
<td>Minocycline Cap</td>
<td>Doxycycline DR</td>
</tr>
<tr>
<td>Tetracycline</td>
<td>Minocycline IR, ER Tab</td>
</tr>
<tr>
<td>Vibramycin Susp <sup>AR</sup></td>
<td>Nuzyra</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=81" rel="noopener">Link to Criteria: Infectious Disease Agents: Antibiotics - Tetracyclines</a></p>
<p><strong>Antifungals</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Fluconazole</td>
<td>Brexafemme</td>
</tr>
<tr>
<td>Flucytosine</td>
<td>Cresemba</td>
</tr>
<tr>
<td>Griseofulvin</td>
<td>Itraconazole</td>
</tr>
<tr>
<td>Ketoconazole</td>
<td>Noxafil Susp</td>
</tr>
<tr>
<td>Terbinafine</td>
<td>Oravig</td>
</tr>
<tr>
<td></td>
<td>Posaconazole</td>
</tr>
<tr>
<td></td>
<td>Tolsura</td>
</tr>
<tr>
<td></td>
<td>Vivjoa</td>
</tr>
<tr>
<td></td>
<td>Voriconazole</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=82" rel="noopener">Link to Criteria: Infectious Disease Agents: Antifungals</a></p>
<p><strong>Antivirals - Hepatitis C Agents</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mavyret <sup>PA</sup></td>
<td>Harvoni</td>
</tr>
<tr>
<td>Pegasys <sup>PA</sup></td>
<td>Ledipasvir/Sofosbuvir</td>
</tr>
<tr>
<td>Ribavirin <sup>PA</sup></td>
<td>Sovaldi</td>
</tr>
<tr>
<td>Sofosbuvir/Velpatasvir <sup>PA</sup></td>
<td>Vosevi</td>
</tr>
<tr>
<td></td>
<td>Zepatier</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=83" rel="noopener">Link to Criteria: Infectious Disease Agents: Antivirals - Hepatitis C Agents</a></p>
<p><strong>Antivirals - Herpes</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Acyclovir</td>
<td>Famciclovir</td>
</tr>
<tr>
<td>Valacyclovir</td>
<td>Sitavig</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=84" rel="noopener">Link to Criteria: Infectious Disease Agents: Antivirals - Herpes</a></p>
<p><strong>Antivirals - HIV</strong>*</p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Abacavir Sulfate</td>
<td>Abacavir Susp</td>
</tr>
<tr>
<td>Abacavir/Lamivudine</td>
<td>Abacavir/Lamivudine/Zidovudine</td>
</tr>
<tr>
<td>Atazanavir Sulfate</td>
<td>Aptivus</td>
</tr>
<tr>
<td>Biktarvy</td>
<td>Didanosine</td>
</tr>
<tr>
<td>Cimduo</td>
<td>Edurant</td>
</tr>
<tr>
<td>Complera</td>
<td>Efavirenz/Lamivudine/Tenofovir Disoproxil Fumarate</td>
</tr>
<tr>
<td>Delstrigo</td>
<td>Emtricitabine</td>
</tr>
<tr>
<td>Descovy</td>
<td>Fosamprenavir</td>
</tr>
<tr>
<td>Dovato</td>
<td>Fuzeon</td>
</tr>
<tr>
<td>Efavirenz</td>
<td>Intelence <sup>BvG</sup></td>
</tr>
<tr>
<td>Efavirenz/Emtricitabine/Tenofovir</td>
<td>Lamivudine Tab</td>
</tr>
<tr>
<td>Emtricitabine/Tenofovir Disoproxil Fumarate</td>
<td>Lamivudine Sol <sup>AR</sup></td>
</tr>
<tr>
<td>Emtriva <sup>BvG</sup></td>
<td>Lamivudine/Zidovudine</td>
</tr>
<tr>
<td>Evotaz</td>
<td>Nevirapine IR, ER Tab</td>
</tr>
<tr>
<td>Genvoya</td>
<td>Nevirapine Sol <sup>AR</sup></td>
</tr>
<tr>
<td>Isentress Chew Tab <sup>AR</sup></td>
<td>Norvir Powder, Sol</td>
</tr>
<tr>
<td>Isentress</td>
<td>Selzentry <sup>BvG</sup></td>
</tr>
<tr>
<td>Juluca</td>
<td>Stavudine</td>
</tr>
<tr>
<td>Lopinavir/Ritonavir</td>
<td>Stribild</td>
</tr>
<tr>
<td>Odefsey</td>
<td>Tybost</td>
</tr>
<tr>
<td>Pifeltro</td>
<td>Viracept</td>
</tr>
<tr>
<td>Prezcobix</td>
<td></td>
</tr>
<tr>
<td>Prezista</td>
<td></td>
</tr>
<tr>
<td>Ritonavir Tab</td>
<td></td>
</tr>
<tr>
<td>Rukobia ER <sup>PA</sup></td>
<td></td>
</tr>
<tr>
<td>Symfi <sup>BvG</sup></td>
<td></td>
</tr>
<tr>
<td>Symfi Lo <sup>BvG</sup></td>
<td></td>
</tr>
<tr>
<td>Symtuza</td>
<td></td>
</tr>
<tr>
<td>Temixys</td>
<td></td>
</tr>
<tr>
<td>Tenofovir Disoproxil Fumarate 300mg</td>
<td></td>
</tr>
<tr>
<td>Tivicay</td>
<td></td>
</tr>
<tr>
<td>Tivicay PD</td>
<td></td>
</tr>
<tr>
<td>Triumeq</td>
<td></td>
</tr>
<tr>
<td>Triumeq PD <sup>PA</sup></td>
<td></td>
</tr>
<tr>
<td>Viread Tab, Powder</td>
<td></td>
</tr>
<tr>
<td>Zidovudine</td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=85" rel="noopener">Link to Criteria: Infectious Disease Agents: Antivirals - HIV</a></p>
<h2 id="ophthalmic_agents">Ophthalmic Agents<a class="headerlink" href="#ophthalmic_agents" title="Permanent link">&para;</a></h2>
<p><strong>Antibiotic and Antibiotic-Steroid Combination Drops and Ointments</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Bacitracin-Polymyxin</td>
<td>Azasite</td>
</tr>
<tr>
<td>Ciloxan</td>
<td>Bacitracin</td>
</tr>
<tr>
<td>Ciprofloxacin</td>
<td>Besivance</td>
</tr>
<tr>
<td>Erythromycin</td>
<td>Blephamide</td>
</tr>
<tr>
<td>Gentamicin</td>
<td>Gatifloxacin</td>
</tr>
<tr>
<td>Moxifloxacin</td>
<td>Levofloxacin</td>
</tr>
<tr>
<td>Neomycin/Polymyxin/Bacitracin</td>
<td>Moxifloxacin (Generic of Moxeza)</td>
</tr>
<tr>
<td>Neomycin/Polymyxin/Bacitracin/Hydrocortisone</td>
<td>Neomycin/Polymyxin/Hydrocortisone</td>
</tr>
<tr>
<td>Neomycin/Polymyxin/Dexamethasone</td>
<td>Pred-G</td>
</tr>
<tr>
<td>Neomycin/Polymyxin/Gramicidin</td>
<td>Sulfacetamide Sodium Ophth Oint 10%</td>
</tr>
<tr>
<td>Ofloxacin</td>
<td>Tobradex ST <sup>BvG</sup></td>
</tr>
<tr>
<td>Polymyxin/Trimethoprim</td>
<td>Zylet</td>
</tr>
<tr>
<td>Sulfacetamide Sodium Ophth Sol 10%</td>
<td></td>
</tr>
<tr>
<td>Sulfacetamide/Prednisolone</td>
<td></td>
</tr>
<tr>
<td>Tobramycin</td>
<td></td>
</tr>
<tr>
<td>Tobramycin/Dexamethasone 0.3/0.1%</td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=86" rel="noopener">Link to Criteria: Ophthalmic Agents: Antibiotic and Antibiotic-Steroid Combination Drops and Ointments</a></p>
<p><strong>Antihistamines &amp; Mast Cell Stabilizers</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Azelastine</td>
<td>Alocril</td>
</tr>
<tr>
<td>Bepreve <sup>BvG</sup></td>
<td>Alomide</td>
</tr>
<tr>
<td>Cromolyn</td>
<td>Epinastine</td>
</tr>
<tr>
<td>Ketotifen</td>
<td>Zerviate</td>
</tr>
<tr>
<td>Olopatadine</td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=87" rel="noopener">Link to Criteria: Ophthalmic Agents: Antihistamines &amp; Mast Cell Stabilizers</a></p>
<p><strong>Dry Eye Treatments</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Restasis Trays <sup>BvG ST</sup></td>
<td>Cequa</td>
</tr>
<tr>
<td></td>
<td>Eysuvis</td>
</tr>
<tr>
<td></td>
<td>Restasis Multi-Dose</td>
</tr>
<tr>
<td></td>
<td>Tyrvaya</td>
</tr>
<tr>
<td></td>
<td>Xiidra</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=88" rel="noopener">Link to Criteria: Ophthalmic Agents: Dry Eye Treatments</a></p>
<p><strong>Glaucoma Agents</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Alphagan P 0.1%</td>
<td>Apraclonidine</td>
</tr>
<tr>
<td>Alphagan P 0.15% <sup>BvG</sup></td>
<td>Betoptic S</td>
</tr>
<tr>
<td>Azopt <sup>BvG ST</sup></td>
<td>Bimatoprost</td>
</tr>
<tr>
<td>Betaxolol</td>
<td>Brimonidine 0.15%</td>
</tr>
<tr>
<td>Brimonidine 0.2%</td>
<td>Brinzolamide</td>
</tr>
<tr>
<td>Carteolol</td>
<td>Iopidine</td>
</tr>
<tr>
<td>Combigan <sup>BvG ST</sup></td>
<td>Istalol</td>
</tr>
<tr>
<td>Dorzolamide</td>
<td>Lumigan</td>
</tr>
<tr>
<td>Dorzolamide/Timolol</td>
<td>Timolol Maleate Droperette</td>
</tr>
<tr>
<td>Latanoprost</td>
<td>Travoprost</td>
</tr>
<tr>
<td>Levobunolol</td>
<td>Vyzulta</td>
</tr>
<tr>
<td>Metipranolol</td>
<td>Xelpros</td>
</tr>
<tr>
<td>Rhopressa</td>
<td>Zioptan <sup>BvG</sup></td>
</tr>
<tr>
<td>Rocklatan</td>
<td>Zioptan <sup>BvG</sup></td>
</tr>
<tr>
<td>Simbrinza</td>
<td></td>
</tr>
<tr>
<td>Timolol 0.5% Gel, Soln</td>
<td></td>
</tr>
<tr>
<td>Travatan Z <sup>BvG ST</sup></td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=89" rel="noopener">Link to Criteria: Ophthalmic Agents: Glaucoma Agents</a></p>
<p><strong>NSAIDs</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Diclofenac</td>
<td>Acuvail</td>
</tr>
<tr>
<td>Flurbiprofen</td>
<td>Bromfenac</td>
</tr>
<tr>
<td>Ketorolac</td>
<td>Bromsite</td>
</tr>
<tr>
<td></td>
<td>Ilevro</td>
</tr>
<tr>
<td></td>
<td>Nevanac</td>
</tr>
<tr>
<td></td>
<td>Prolensa</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=90" rel="noopener">Link to Criteria: Ophthalmic Agents: NSAIDs</a></p>
<p><strong>Ophthalmic Steroids</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Alrex <sup>BvG</sup></td>
<td>Inveltys</td>
</tr>
<tr>
<td>Dexamethasone Sodium Phosphate</td>
<td>Lotemax SM</td>
</tr>
<tr>
<td>Difluprednate</td>
<td>Loteprednol</td>
</tr>
<tr>
<td>Durezol</td>
<td></td>
</tr>
<tr>
<td>Flarex</td>
<td></td>
</tr>
<tr>
<td>Fluorometholone</td>
<td></td>
</tr>
<tr>
<td>Fml Forte</td>
<td></td>
</tr>
<tr>
<td>Fml S.O.P.</td>
<td></td>
</tr>
<tr>
<td>Lotemax <sup>BvG</sup></td>
<td></td>
</tr>
<tr>
<td>Maxidex</td>
<td></td>
</tr>
<tr>
<td>Pred Forte</td>
<td></td>
</tr>
<tr>
<td>Pred Mild</td>
<td></td>
</tr>
<tr>
<td>Prednisolone Acetate</td>
<td></td>
</tr>
<tr>
<td>Prednisolone Sodium Phosphate</td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=91" rel="noopener">Link to Criteria: Ophthalmic Agents: Ophthalmic Steroids</a></p>
<h2 id="otic_agents">Otic Agents<a class="headerlink" href="#otic_agents" title="Permanent link">&para;</a></h2>
<p><strong>Antibacterial and Antibacterial/Steroid Combinations</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Cipro HC</td>
<td>Ciprofloxacin</td>
</tr>
<tr>
<td>Ciprodex <sup>BvG</sup></td>
<td>Ciprofloxacin/Dexamethasone</td>
</tr>
<tr>
<td>Cortisporin-TC</td>
<td>Ciprofloxacin/Fluocinolone</td>
</tr>
<tr>
<td>Neomycin/Polymyxin B/Hydrocortisone</td>
<td></td>
</tr>
<tr>
<td>Ofloxacin</td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=92" rel="noopener">Link to Criteria: Otic Agents: Antibacterial and Antibacterial/Steroid Combinations</a></p>
<h2 id="respiratory_agents">Respiratory Agents<a class="headerlink" href="#respiratory_agents" title="Permanent link">&para;</a></h2>
<p><strong>Antihistamines - Second Generation</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Cetirizine Syr, Tab <sup>QL</sup></td>
<td>Cetirizine Chewable <sup>AR</sup></td>
</tr>
<tr>
<td>Cetirizine/Pseudoephedrine</td>
<td>Clarinex-D</td>
</tr>
<tr>
<td>Loratadine Rapid Dissolve <sup>QL</sup></td>
<td>Desloratadine</td>
</tr>
<tr>
<td>Loratadine Syr, Tab <sup>QL</sup></td>
<td>Fexofenadine</td>
</tr>
<tr>
<td>Loratadine/Pseudoephedrine</td>
<td>Levocetirizine</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=93" rel="noopener">Link to Criteria: Respiratory Agents: Antihistamines - Second Generation</a></p>
<p><strong>Cystic Fibrosis</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kalydeco <sup>PA QL</sup></td>
<td>Bronchitol</td>
</tr>
<tr>
<td>Orkambi <sup>PA QL</sup></td>
<td></td>
</tr>
<tr>
<td>Symdeko <sup>PA QL</sup></td>
<td></td>
</tr>
<tr>
<td>Trikafta <sup>PA</sup></td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=94" rel="noopener">Link to Criteria: Respiratory Agents: Cystic Fibrosis</a></p>
<p><strong>Eninephrine Auto-Injectors</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Epinephrine (labeler 49502)</td>
<td>Epipen</td>
</tr>
<tr>
<td>Symjepi</td>
<td>Epipen JR</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=95" rel="noopener">Link to Criteria: Respiratory Agents: Eninephrine Auto-Injectors</a></p>
<p><strong>Hereditary Angioedema</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Haegarda <sup>PA</sup></td>
<td>Berinert</td>
</tr>
<tr>
<td>Ruconest <sup>PA</sup></td>
<td>Cinryze</td>
</tr>
<tr>
<td>Takhzyro <sup>PA</sup></td>
<td>Icatibant Acetate</td>
</tr>
<tr>
<td></td>
<td>Kalbitor</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=96" rel="noopener">Link to Criteria: Respiratory Agents: Hereditary Angioedema</a></p>
<p><strong>Inhaled Agents</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Advair Diskus <sup>BvG</sup></td>
<td>Aerospan HFA</td>
</tr>
<tr>
<td>Advair HFA <sup>BvG</sup></td>
<td>Airduo Digihaler, Respiclick</td>
</tr>
<tr>
<td>Albuterol HFA</td>
<td>Alvesco</td>
</tr>
<tr>
<td>Albuterol Nebulizer Sol 0.021% (0.63mg/3mL), 0.042% (1.25mg/3mL) <sup>AR</sup></td>
<td>Armorair Digihaler, Respiclick</td>
</tr>
<tr>
<td>Albuterol Nebulizer Sol 0.083% (2.5mg/3mL), 0.5% (5mg/mL) Conc</td>
<td>Arformoterol Nebulizer Sol</td>
</tr>
<tr>
<td>Albuterol Nebulizer Sol 0/083% (2.5mg/3mL), 0.5%</td>
<td>Anoro Ellipta</td>
</tr>
<tr>
<td>Anoro Ellipta</td>
<td>Asmanex HFA</td>
</tr>
<tr>
<td>Asmanex Twisthaler</td>
<td>Bevespi Aerosphere</td>
</tr>
<tr>
<td>Atrovent HFA <sup>QL</sup></td>
<td>Breo Ellipta <sup>BvG</sup></td>
</tr>
<tr>
<td>Budesonide Nebulizer Sol <sup>AR QL</sup></td>
<td>Breztri Aerosphere</td>
</tr>
<tr>
<td>Combivent Respimat</td>
<td>Budesonide/Formeterol <sup>QL</sup></td>
</tr>
<tr>
<td>Cromolyn Neb Sol</td>
<td>Duaklir Pressair</td>
</tr>
<tr>
<td>Dulera</td>
<td>Fluticasone/Salmeterol</td>
</tr>
<tr>
<td>Flovent <sup>BvG QL</sup></td>
<td>Formeterol Fumarate Nebulizer Sol</td>
</tr>
<tr>
<td>Incruse Ellipta</td>
<td>Levalbuterol Nebulizer Sol</td>
</tr>
<tr>
<td>Ipratropium</td>
<td>Lonhala Magnair</td>
</tr>
<tr>
<td>Ipratropium/Albuterol Nebulizer Sol <sup>QL</sup></td>
<td>Proair Digihaler, Respiclick</td>
</tr>
<tr>
<td>Proair HFA</td>
<td>Qvar <sup>QL</sup></td>
</tr>
<tr>
<td>Proventil HFA</td>
<td>Trelegy Ellipta</td>
</tr>
<tr>
<td>Pulmicort Flexhaler <sup>QL</sup></td>
<td>Tudorza</td>
</tr>
<tr>
<td>Serevent Diskus</td>
<td>Wixela Inhub</td>
</tr>
<tr>
<td>Spiriva <sup>QL</sup></td>
<td>Xopenex HFA</td>
</tr>
<tr>
<td>Stiolto</td>
<td>Yupelri</td>
</tr>
<tr>
<td>Striverdi Respimat</td>
<td></td>
</tr>
<tr>
<td>Symbicort <sup>BvG QL</sup></td>
<td></td>
</tr>
<tr>
<td>Ventolin HFA <sup>BvG</sup></td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=97" rel="noopener">Link to Criteria: Respiratory Agents Inhaled Agents</a></p>
<p><strong>Leukotriene Receptor Modifiers &amp; Inhibitors</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Montelukast <sup>QL</sup></td>
<td>Zileuton</td>
</tr>
<tr>
<td>Zafirlukast <sup>ST</sup></td>
<td>Zyflo</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=98" rel="noopener">Link to Criteria: Respiratory Agents: Leukotriene Receptor Modifiers &amp; Inhibitors</a></p>
<p><strong>Monoclonal Antibodies-Anti-IL/Anti-IgE</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Fasenra <sup>PA</sup></td>
<td>Nucala</td>
</tr>
<tr>
<td>Dupixent <sup>PA</sup></td>
<td>Tezspire</td>
</tr>
<tr>
<td>Xolair <sup>PA</sup></td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=99" rel="noopener">Link to Criteria: Respiratory Agents: Monoclonal Antibodies-Anti-IL/Anti-IgE</a></p>
<p><strong>Nasal Preparations</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Azelastine</td>
<td>Azelastine/Fluticasone Spray</td>
</tr>
<tr>
<td>Flunisolide</td>
<td>Beconase AQ</td>
</tr>
<tr>
<td>Fluticasone (Generic of Flonase)</td>
<td>Budesonide</td>
</tr>
<tr>
<td>Ipratropium <sup>QL</sup></td>
<td>Mometasone</td>
</tr>
<tr>
<td>Olopatadine</td>
<td>Omnaris</td>
</tr>
<tr>
<td></td>
<td>Qnasl</td>
</tr>
<tr>
<td></td>
<td>Ryaltris</td>
</tr>
<tr>
<td></td>
<td>Xhance</td>
</tr>
<tr>
<td></td>
<td>Zetonna</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=100" rel="noopener">Link to Criteria: Respiratory Agents: Nasal Preparations</a></p>
<p><strong>Other Agents</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td></td>
<td>Roflumilast</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=101" rel="noopener">Link to Criteria: Respiratory Agents: Other Agents</a></p>
<h2 id="topical_agents">Topical Agents<a class="headerlink" href="#topical_agents" title="Permanent link">&para;</a></h2>
<p><strong>Antifungals</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Alevazol</td>
<td>Butenafine</td>
</tr>
<tr>
<td>Ciclopirox</td>
<td>Ciclopirox Kit</td>
</tr>
<tr>
<td>Clotrimazole</td>
<td>Ertaczo</td>
</tr>
<tr>
<td>Clotrimazole/Betamethasone</td>
<td>Jublia</td>
</tr>
<tr>
<td>Econazole</td>
<td>Ketoconazole Foam</td>
</tr>
<tr>
<td>Ketoconazole</td>
<td>Luliconazole</td>
</tr>
<tr>
<td>Miconazole</td>
<td>Miconazole/Zinc Oxide/White Petrolatum Oint</td>
</tr>
<tr>
<td>Nystatin</td>
<td>Naftifine</td>
</tr>
<tr>
<td>Nystatin/Triamcinolone</td>
<td>Oxiconazole</td>
</tr>
<tr>
<td>Terbinafine</td>
<td>Tavaborole</td>
</tr>
<tr>
<td>Tolnaftate</td>
<td></td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=102" rel="noopener">Link to Criteria: Topical Agents: Antifungals</a></p>
<p><strong>Antiparasitics</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Natroba <sup>BvG</sup></td>
<td>Eurax</td>
</tr>
<tr>
<td>Permethrin</td>
<td>Ivermectin Lot</td>
</tr>
<tr>
<td>Piperonyl Butoxide/Pyrethrins</td>
<td>Malathion</td>
</tr>
<tr>
<td></td>
<td>Spinosad</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=103" rel="noopener">Link to Criteria: Topical Agents: Antiparasitics</a></p>
<p><strong>Corticosteroids</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Amcinonide</td>
<td>Alclometasone</td>
</tr>
<tr>
<td>Betamethasone Dip/Calcipotriene Oint</td>
<td>Apexicon E</td>
</tr>
<tr>
<td>Betamethasone Valerate</td>
<td>Betamethasone Dipropionate</td>
</tr>
<tr>
<td>Clobetasol Propionate</td>
<td>Betamethasone Dipropionate/Calcipotriene Susp</td>
</tr>
<tr>
<td>Derma-Smoothe/FS <sup>BvG</sup></td>
<td>Betamethasone Valerate Aerosol Foam</td>
</tr>
<tr>
<td>Desonide Cream, Oint</td>
<td>Bryhali</td>
</tr>
<tr>
<td>Diflorasone Diacetate</td>
<td>Clocortolone Pivalate</td>
</tr>
<tr>
<td>Fluocinolone Acetonide 0.01% Cream, Sol, 0.05%</td>
<td>Cordran Tape</td>
</tr>
<tr>
<td>Flurandrenolide</td>
<td>Desonate Gel</td>
</tr>
<tr>
<td>Fluticasone Propionate Cream, Oint</td>
<td>Desonide Lotion</td>
</tr>
<tr>
<td>Hydrocortisone</td>
<td>Desoximetasone</td>
</tr>
<tr>
<td>Mometasone Furoate</td>
<td>Fluocinolone Acetonide 0.01% Oil</td>
</tr>
<tr>
<td>Prednicarbate</td>
<td>Fluocinolone Acetonide 0.025%, 0.1%</td>
</tr>
<tr>
<td>Triamcinolone</td>
<td>Fluticasone Propionate Lotion</td>
</tr>
<tr>
<td></td>
<td>Halcinonide Cream</td>
</tr>
<tr>
<td></td>
<td>Halobetasol Propionate</td>
</tr>
<tr>
<td></td>
<td>Hydrocortisone Butyrate, Valerate</td>
</tr>
<tr>
<td></td>
<td>Halog</td>
</tr>
<tr>
<td></td>
<td>Impeklo</td>
</tr>
<tr>
<td></td>
<td>Pandel</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=104" rel="noopener">Link to Criteria: Topical Agents: Corticosteroids</a></p>
<p><strong>Immunomodulators</strong></p>
<table>
<thead>
<tr>
<th>Preferred</th>
<th>Non-Preferred</th>
</tr>
</thead>
<tbody>
<tr>
<td>Elidel <sup>AR BvG ST</sup></td>
<td>Eucrisa</td>
</tr>
<tr>
<td>Tacrolimus <sup>AR ST</sup></td>
<td>Hyftor</td>
</tr>
<tr>
<td></td>
<td>Opzelura</td>
</tr>
<tr>
<td></td>
<td>Pimecrolimus <sup>AR</sup></td>
</tr>
<tr>
<td></td>
<td>Vtama</td>
</tr>
<tr>
<td></td>
<td>Zoryve</td>
</tr>
</tbody>
</table>
<p><a :target="_blank" href="https://spbm.medicaid.ohio.gov/SPDocumentLibrary/DocumentLibrary/UPDL/UPDL%20criteria%20effective%2001.01.2024.pdf#page=105" rel="noopener">Link to Criteria: Topical Agents: Immunomodulators</a></p>







  
  






                
              </article>
            </div>
          
          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
      </main>
      
        <footer class="md-footer">
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    <script id="__config" type="application/json">{"base": "../../..", "features": ["navigation.instant", "navigation.tabs", "navigation.prune", "search.highlight", "content.action.edit"], "search": "../../../assets/javascripts/workers/search.6ce7567c.min.js", "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}}</script>
    
    
      <script src="../../../assets/javascripts/bundle.56dfad97.min.js"></script>
      
    
  </body>
</html>